,Diabetes: Hemoglobin A1c Poor Control,122v4,0059,001,Percentage of patients 18-75 years of age with diabetes who had hemoglobin A1c > 9.0% during the measurement period,Effective Clinical Care, Intermediate Outcome,National Committee for Quality Assurance,-,-,X,-,X,X,X,X,"Diabetic Mellitus
Diabetic Retinopathy",X,X,-,-,X,-,Measure Specification Manuals
,Diabetes: Low Density Lipoprotein (LDL-C) Control (<100 mg/dL),163v4,N/A,002,Percentage of patients 18–75 years of age with diabetes whose LDL-C was adequately controlled (< 100 mg/dL) during the measurement period,Effective Clinical Care, Intermediate Outcome,National Committee for Quality Assurance,-,-,-,-,X,-,-,-,-,-,-,-,-,X,X,Measure Specification Manuals
,Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) Therapy for Left Ventricular Systolic Dysfunction (LVSD),135v4,0081,005,Percentage of patients aged 18 years and older with a diagnosis of heart failure (HF) with a current or prior left ventricular ejection fraction (LVEF) < 40% who were prescribed ACE inhibitor or ARB therapy either within a 12 month period when seen in the outpatient setting OR at each hospital discharge,Effective Clinical Care,Process,American Medical Association-Physician Consortium for Performance Improvement,American College of Cardiology Foundation,American Heart Association,-,-,X,-,X,X,Heart Failure,-,-,-,-,X,-,Measure Specification Manuals
,Coronary Artery Disease (CAD): Antiplatelet Therapy,N/A,0067,006,Percentage of patients aged 18 years and older with a diagnosis of coronary artery disease (CAD) seen within a 12 month period who were prescribed aspirin or clopidogrel,Effective Clinical Care,Process,American College of Cardiology,American Heart Association,American Medical Association-Physician Consortium for Performance Improvement,-,-,-,-,X,X,Coronary Artery Disease,-,X,-,-,-,-,Measure Specification Manuals
,Coronary Artery Disease (CAD): Beta-Blocker Therapy – Prior Myocardial Infarction (MI) or Left Ventricular Systolic Dysfunction (LVEF < 40%),145v4,0070,007,Percentage of patients aged 18 years and older with a diagnosis of coronary artery disease seen within a 12 month period who also have prior MI OR a current or prior LVEF < 40% who were prescribed beta-blocker therapy ,Effective Clinical Care,Process,American Medical Association-Physician Consortium for Performance Improvement,American College of Cardiology Foundation,American Heart Association,-,-,X,-,X,X,Coronary Artery Disease,-,-,-,-,X,-,Measure Specification Manuals
,Heart Failure (HF): Beta-Blocker Therapy for Left Ventricular Systolic Dysfunction (LVSD),144v4,0083,008,Percentage of patients aged 18 years and older with a diagnosis of heart failure (HF) with a current or prior left ventricular ejection fraction (LVEF) < 40% who were prescribed beta-blocker therapy either within a 12 month period when seen in the outpatient setting OR at each hospital discharge,Effective Clinical Care,Process,American Medical Association-Physician Consortium for Performance Improvement,American College of Cardiology Foundation,American Heart Association,-,-,X,X,X,X,Heart Failure,-,X,-,-,X,-,Measure Specification Manuals
,Anti-Depressant Medication Management,128v4,0105,009,"Percentage of patients 18 years of age and older who were diagnosed with major depression and treated with antidepressant medication,   and who remained on antidepressant medication treatment. Two rates are reported
a. Percentage of patients who remained on an antidepressant medication for at least 84 days (12 weeks).
b. Percentage of patients who remained on an antidepressant medication for at least 180 days (6 months).
",Effective Clinical Care,Process,National Committee for Quality Assurance,-,-,-,-,X,-,-,-,-,-,-,-,-,X,-,Measure Specification Manuals
,Primary Open-Angle Glaucoma (POAG): Optic Nerve Evaluation,143v4,0086,012,Percentage of patients aged 18 years and older with a diagnosis of primary open-angle glaucoma (POAG) who have an optic nerve head evaluation during one or more office visits within 12 months,Effective Clinical Care,Process,American Medical Association-Physician Consortium for Performance Improvement,National Committee for Quality Assurance,-,X,-,X,-,-,X,-,-,-,-,-,X,-,Measure Specification Manuals
,Age-Related Macular Degeneration (AMD): Dilated Macular Examination,N/A,0087,014,Percentage of patients aged 50 years and older with a diagnosis of age-related macular degeneration (AMD) who had a dilated macular examination performed which included documentation of the presence or absence of macular thickening or hemorrhage AND the level of macular degeneration severity during one or more office visits within 12 months,Effective Clinical Care,Process,American Academy of Ophthalmology,-,-,X,-,-,-,-,X,-,-,-,-,-,-,-,Measure Specification Manuals
,Diabetic Retinopathy: Documentation of Presence or Absence of Macular Edema and Level of Severity of Retinopathy,167v4,0088,018,Percentage of patients aged 18 years and older with a diagnosis of diabetic retinopathy who had a dilated macular or fundus exam performed which included documentation of the level of severity of retinopathy and the presence or absence of macular edema during one or more office visits within 12 months,Effective Clinical Care,Process,American Medical Association-Physician Consortium for Performance Improvement,National Committee for Quality Assurance,-,-,-,X,-,X,-,Diabetic Retinopathy,-,-,-,-,X,-,Measure Specification Manuals
,Diabetic Retinopathy: Communication with the Physician Managing Ongoing Diabetes Care,142v4,0089,019,Percentage of patients aged 18 years and older with a diagnosis of diabetic retinopathy who had a dilated macular or fundus exam performed with documented communication to the physician who manages the ongoing care of the patient with diabetes mellitus regarding the findings of the macular or fundus exam at least once within 12 months,Communication and Care Coordination ,Process,American Medical Association-Physician Consortium for Performance Improvement,National Committee for Quality Assurance,-,X,-,X,-,X,X,Diabetic Retinopathy,-,-,-,-,X,-,Measure Specification Manuals
,Perioperative Care: Selection of Prophylactic Antibiotic – First OR Second Generation Cephalosporin,N/A,0268,021,"Percentage of surgical patients aged 18 years and older undergoing procedures with the indications for a first OR second generation cephalosporin prophylactic antibiotic, who had an order for a first OR second generation cephalosporin for antimicrobial prophylaxis",Patient Safety,Process,American Medical Association-Physician Consortium for Performance Improvement,National Committee for Quality Assurance,-,X,-,-,-,-,X,-,-,-,-,-,-,-,Measure Specification Manuals
,Perioperative Care: Discontinuation of Prophylactic Parenteral Antibiotics (Non-Cardiac Procedures),N/A,0271,022,"Percentage of non-cardiac surgical patients aged 18 years and older undergoing procedures with the indications for prophylactic parenteral antibiotics AND who received a prophylactic parenteral antibiotic, who have an order for discontinuation of prophylactic parenteral antibiotics within 24 hours of surgical end time",Patient Safety,Process,American Medical Association-Physician Consortium for Performance Improvement,National Committee for Quality Assurance,-,X,-,-,-,-,X,-,-,-,-,-,-,-,Measure Specification Manuals
,Perioperative Care: Venous Thromboembolism (VTE) Prophylaxis (When Indicated in ALL Patients),N/A,0239,023,"Percentage of surgical patients aged 18 years and older undergoing procedures for which VTE prophylaxis is indicated in all patients, who had an order for Low Molecular Weight Heparin (LMWH), Low-Dose Unfractionated Heparin (LDUH), adjusted-dose warfarin, fondaparinux or mechanical prophylaxis to be given within 24 hours prior to incision time or within 24 hours after surgery end time",Patient Safety,Process,American Medical Association-Physician Consortium for Performance Improvement,National Committee for Quality Assurance,-,X,-,-,-,-,X,-,-,-,-,-,-,-,Measure Specification Manuals
,Communication with the Physician or Other Clinician Managing On-going Care Post-Fracture for Men and Women Aged 50 Years and Older,N/A,0045,024,"Percentage of patients aged 50 years and older treated for a fracture with documentation of communication, between the physician treating the fracture and the physician or other clinician managing the patient’s on-going care, that a fracture occurred and that the patient was or should be considered for osteoporosis treatment or testing. This measure is reported by the physician who treats the fracture and who therefore is held accountable for the communication",Communication and Care Coordination,Process,National Committee for Quality Assurance,American Medical Association-Physician Consortium for Performance Improvement,-,X,-,-,-,-,X,-,-,-,-,-,-,-,Measure Specification Manuals
,Stroke and Stroke Rehabilitation: Discharged on Antithrombotic Therapy,N/A,0325,032,"Percentage of patients aged 18 years and older with a diagnosis of ischemic stroke or transient ischemic attack (TIA) with documented permanent, persistent, or paroxysmal atrial fibrillation who were prescribed an antithrombotic at discharge",Effective Clinical Care,Process,American Academy of Neurology,-,-,X,-,-,-,-,X,-,-,-,-,-,-,-,Measure Specification Manuals
,Screening for Osteoporosis for Women Aged 65-85 Years of Age,N/A,0046,039,Percentage of female patients aged 65-85 years of age who ever had a central dual-energy X-ray absorptiometry (DXA) to check for osteoporosis,Effective Clinical Care,Process,National Committee for Quality Assurance,American Medical Association-Physician Consortium for Performance Improvement,-,X,-,-,-,X,X,Preventive Care,-,-,-,-,-,-,Measure Specification Manuals
,Osteoporosis: Pharmacologic Therapy for Men and Women Aged 50 Years and Older,N/A,N/A,041,Percentage of patients aged 50 years and older with a diagnosis of osteoporosis who were prescribed pharmacologic therapy within 12 months,Effective Clinical Care,Process,National Committee for Quality Assurance,American Medical Association-Physician Consortium for Performance Improvement,-,X,-,-,-,-,X,-,-,-,-,-,-,-,Measure Specification Manuals
,Coronary Artery Bypass Graft (CABG): Use of Internal Mammary Artery (IMA) in Patients with Isolated CABG Surgery,N/A,0134,043, Percentage of patients aged 18 years and older undergoing isolated CABG surgery who received an IMA graft,Effective Clinical Care,Process,Society of Thoracic Surgeons,-,-,-,-,-,-,X,X,Coronary Artery Bypass Graft,-,-,-,-,-,-,Measure Specification Manuals
,Coronary Artery Bypass Graft (CABG): Preoperative Beta-Blocker in Patients with Isolated CABG Surgery,N/A,0236,044,Percentage of isolated Coronary Artery Bypass Graft (CABG) surgeries for patients aged 18 years and older who received a beta-blocker within 24 hours prior to surgical incision,Effective Clinical Care,Process,Centers for Medicare & Medicaid Services,Quality Insights of Pennsylvania,-,-,-,-,-,X,X,Coronary Artery Bypass Graft,-,-,-,-,-,-,Measure Specification Manuals
,Medication Reconciliation Post-Discharge,N/A,0097,046,"The percentage of discharges from any inpatient facility (e.g. hospital, skilled nursing facility, or rehabilitation facility) for patients 18 years and older of age seen within 30 days following discharge in the office by the physician, prescribing practitioner, registered nurse, or clinical pharmacist providing on-going care for whom the discharge medication list was reconciled with the current medication list in the outpatient medical record. 
This measure is reported as three rates stratified by age group: 

• Reporting Criteria 1: 18-64 years of age 
• Reporting Criteria 2: 65 years and older 
• Total Rate: All patients 18 years of age and older",Communication and Care Coordination,Process,National Committee for Quality Assurance,American Medical Association-Physician Consortium for Performance Improvement,-,X,-,-,-,-,X,-,X,-,-,-,-,-,Measure Specification Manuals
,Care Plan,N/A,0326,047,Percentage of patients aged 65 years and older who have an advance care plan or surrogate decision maker documented in the medical record or documentation in the medical record that an advance care plan was discussed but the patient did not wish or was not able to name a surrogate decision maker or provide an advance care plan.,Communication and Care Coordination,Process,National Committee for Quality Assurance,American Medical Association-Physician Consortium for Performance Improvement,-,X,-,-,-,X,X,"Chronic Kidney Disease
Heart Failure
HIV/AIDS
Parkinson's Disease
Chronic Obstructive Pulmonary Disorder 
Dementia
Multiple Chronic Conditions",X,-,-,-,-,-,Measure Specification Manuals
,Urinary Incontinence: Assessment of Presence or Absence of Urinary Incontinence in Women Aged 65 Years and Older,N/A,N/A,048,Percentage of female patients aged 65 years and older who were assessed for the presence or absence of urinary incontinence within 12 months,Effective Clinical Care,Process,National Committee for Quality Assurance,American Medical Association-Physician Consortium for Performance Improvement,-,X,-,-,-,X,X,Preventive Care,-,-,-,-,-,-,Measure Specification Manuals
,Urinary Incontinence: Plan of Care for Urinary Incontinence in Women Aged 65 Years and Older,N/A,N/A,050,Percentage of female patients aged 65 years and older with a diagnosis of urinary incontinence with a documented plan of care for urinary incontinence at least once within 12 months,Person and Caregiver-Centered Experience and Outcomes,Process,National Committee for Quality Assurance,American Medical Association-Physician Consortium for Performance Improvement,-,X,-,-,-,-,X,-,-,-,-,-,-,-,Measure Specification Manuals
,Chronic Obstructive Pulmonary Disease (COPD): Spirometry Evaluation,N/A,0091,051,Percentage of patients aged 18 years and older with a diagnosis of COPD who had spirometry results documented,Effective Clinical Care,Process,American Thoracic Society,-,-,X,-,-,-,X,X,Chronic Obstructive Pulmonary Disorder,-,-,-,-,-,-,Measure Specification Manuals
,Chronic Obstructive Pulmonary Disease (COPD): Inhaled Bronchodilator Therapy,N/A,0102,052,Percentage of patients aged 18 years and older with a diagnosis of COPD and who have an FEV1 less than 60% predicted and have symptoms who were prescribed an inhaled bronchodilator.,Effective Clinical Care,Process,American Thoracic Society,-,-,X,-,-,-,X,X,Chronic Obstructive Pulmonary Disorder,-,-,-,-,-,-,Measure Specification Manuals
,Asthma: Pharmacologic Therapy for Persistent Asthma - Ambulatory Care Setting,N/A,0047,053,Percentage of patients aged 5 years and older with a diagnosis of persistent asthma who were prescribed long-term control medication,Effective Clinical Care,Process,"American Academy of Allergy, Asthma, and Immunology",American Medical Association-Physician Consortium for Performance Improvement,National Committee for Quality Assurance,-,-,-,-,X,X,Asthma,-,-,-,-,-,-,Measure Specification Manuals
,Emergency Medicine: 12-Lead Electrocardiogram (ECG) Performed for Non-Traumatic Chest Pain,N/A,0090,054,Percentage of patients aged 40 years and older with an emergency department discharge diagnosis of non-traumatic chest pain who had a 12-lead electrocardiogram (ECG) performed,Effective Clinical Care,Process,American Medical Association-Physician Consortium for Performance Improvement,National Committee for Quality Assurance,-,X,-,-,-,-,X,-,-,-,-,-,-,-,Measure Specification Manuals
,Appropriate Treatment for Children with Upper Respiratory Infection (URI),154v4,0069,065,Percentage of children 3 months through 18 years of age who were diagnosed with upper respiratory infection (URI) and were not dispensed an antibiotic prescription on or three days after the episode,Efficiency and Cost Reduction,Process,National Committee for Quality Assurance,-,-,-,-,X,-,-,X,-,-,-,-,-,X,-,Measure Specification Manuals
,Appropriate Testing for Children with Pharyngitis,146v4,0002,066,"Percentage of children 3-18 years of age who were diagnosed with pharyngitis, ordered an antibiotic and received a group A streptococcus (strep) test for the episode",Efficiency and Cost Reduction,Process,National Committee for Quality Assurance,-,-,-,-,X,-,-,X,-,-,-,-,-,X,-,Measure Specification Manuals
,Hematology: Myelodysplastic Syndrome (MDS) and Acute Leukemia: Baseline Cytogenetic Testing Performed on Bone Marrow,N/A,0377,067,Percentage of patients aged 18 years and older with a diagnosis of myelodysplastic syndrome (MDS) or an acute leukemia who had baseline cytogenetic testing performed on bone marrow,Effective Clinical Care,Process,American Medical Association-Physician Consortium for Performance Improvement,American Society of Hematology,-,-,-,-,-,-,X,-,-,-,-,-,-,-,Measure Specification Manuals
,Hematology: Myelodysplastic Syndrome (MDS): Documentation of Iron Stores in Patients Receiving Erythropoietin Therapy,N/A,0378,068,Percentage of patients aged 18 years and older with a diagnosis of myelodysplastic syndrome (MDS) who are receiving erythropoietin therapy with documentation of iron stores within 60 days prior to initiating erythropoietin therapy,Effective Clinical Care,Process,American Medical Association-Physician Consortium for Performance Improvement,American Society of Hematology,-,-,-,-,-,-,X,-,-,-,-,-,-,-,Measure Specification Manuals
,Hematology: Multiple Myeloma: Treatment with Bisphosphonates,N/A,0380,069,"Percentage of patients aged 18 years and older with a diagnosis of multiple myeloma, not in remission, who were prescribed or received intravenous bisphosphonate therapy within the 12-month reporting period",Effective Clinical Care,Process,American Medical Association-Physician Consortium for Performance Improvement,American Society of Hematology,-,-,-,-,-,-,X,-,-,-,-,-,-,-,Measure Specification Manuals
,Hematology: Chronic Lymphocytic Leukemia (CLL): Baseline Flow Cytometry,N/A,0379,070,Percentage of patients aged 18 years and older seen within a 12 month reporting period with a diagnosis of chronic lymphocytic leukemia (CLL) made at any time during or prior to the reporting period who had baseline flow cytometry studies performed and documented in the chart,Effective Clinical Care,Process,American Medical Association-Physician Consortium for Performance Improvement,American Society of Hematology,-,-,-,-,-,-,X,-,-,-,-,-,-,-,Measure Specification Manuals
,Breast Cancer: Hormonal Therapy for Stage IC -IIIC Estrogen Receptor/Progesterone Receptor (ER/PR) Positive Breast Cancer,140v4,0387,071,"Percentage of female patients aged 18 years and older with Stage IC through IIIC, ER or PR positive breast cancer who were prescribed tamoxifen or aromatase inhibitor (AI) during the 12-month reporting period",Effective Clinical Care,Process,American Medical Association-Physician Consortium for Performance Improvement,American Society of Clinical Oncology,National Comprehensive Cancer Network,X,-,X,-,X,X,Oncology,-,-,-,-,X,-,Measure Specification Manuals
,Colon Cancer: Chemotherapy for AJCC Stage III Colon Cancer Patients,141v5,0385,072,"Percentage of patients aged 18 through 80 years with AJCC Stage III colon cancer who are referred for adjuvant chemotherapy, prescribed adjuvant chemotherapy, or have previously received adjuvant chemotherapy within the 12-month reporting period",Effective Clinical Care,Process,American Medical Association-Physician Consortium for Performance Improvement,American Society of Clinical Oncology,National Comprehensive Cancer Network,X,-,X,-,X,X,Oncology,-,-,-,-,X,-,Measure Specification Manuals
,Prevention of Central Venous Catheter (CVC)-Related Bloodstream Infections,N/A,N/A,076,"Percentage of patients, regardless of age, who undergo central venous catheter (CVC) insertion for whom CVC was inserted with all elements of maximal sterile barrier technique, hand hygiene, skin preparation and, if ultrasound is used, sterile ultrasound techniques followed",Patient Safety,Process,American Society of Anesthesiologists,-,-,X,-,-,-,-,X,-,-,-,-,-,-,-,Measure Specification Manuals
,Hepatitis C: Ribonucleic Acid (RNA) Testing Before Initiating Treatment,N/A,0395,084,Percentage of patients aged 18 years and older with a diagnosis of chronic hepatitis C who started antiviral treatment within the 12 month reporting period for whom quantitative hepatitis C virus (HCV) ribonucleic acid (RNA) testing was performed within 12 months prior to initiation of antiviral treatment,Effective Clinical Care,Process,American Medical Association-Physician Consortium for Performance Improvement,American Gastroenterological Association,-,-,-,-,-,X,-,Hepatitis C,-,-,-,-,-,-,Measure Specification Manuals
,Hepatitis C: Hepatitis C Virus (HCV) Genotype Testing Prior to Treatment,N/A,0396,085,Percentage of patients aged 18 years and older with a diagnosis of chronic hepatitis C who started antiviral treatment within the 12 month reporting period for whom hepatitis C virus (HCV) genotype testing was performed within 12 months prior to initiation of antiviral treatment,Effective Clinical Care,Process,American Medical Association-Physician Consortium for Performance Improvement,American Gastroenterological Association,-,-,-,-,-,X,-,Hepatitis C,-,-,-,-,-,-,Measure Specification Manuals
,Hepatitis C: Hepatitis C Virus (HCV) Ribonucleic Acid (RNA) Testing Between 4-12 Weeks After Initiation of Treatment,N/A,0398,087,Percentage of patients aged 18 years and older with a diagnosis of chronic hepatitis C who are receiving antiviral treatment for whom quantitative hepatitis C virus (HCV) ribonucleic acid (RNA) testing was performed between 4-12 weeks after the initiation of antiviral treatment,Effective Clinical Care,Process,American Medical Association-Physician Consortium for Performance Improvement,American Gastroenterological Association,-,-,-,-,-,X,-,Hepatitis C,-,-,-,-,-,-,Measure Specification Manuals
,Acute Otitis Externa (AOE): Topical Therapy,N/A,0653,091,Percentage of patients aged 2 years and older with a diagnosis of AOE who were prescribed topical preparations,Effective Clinical Care,Process,American Academy of Otolaryngology-Head and Neck Surgery,-,-,X,-,-,-,X,X,Acute Otitis Externa (AOE) ,-,-,-,-,-,-,Measure Specification Manuals
,Acute Otitis Externa (AOE): Systemic Antimicrobial Therapy – Avoidance of Inappropriate Use,N/A,0654,093,Percentage of patients aged 2 years and older with a diagnosis of AOE who were not prescribed systemic antimicrobial therapy,Efficiency and Cost Reduction,Process,American Academy of Otolaryngology-Head and Neck Surgery,-,-,X,-,-,-,X,X,Acute Otitis Externa (AOE),-,-,-,-,-,-,Measure Specification Manuals
,Breast Cancer Resection Pathology Reporting: pT Category (Primary Tumor) and pN Category (Regional Lymph Nodes) with Histologic Grade,N/A,0391,099,"Percentage of breast cancer resection pathology reports that include the pT category (primary tumor), the pN category (regional lymph nodes), and the histologic grade",Effective Clinical Care,Process,College of American Pathologists,-,-,X,-,-,-,-,X,-,-,-,-,-,-,-,Measure Specification Manuals
,Colorectal Cancer Resection Pathology Reporting: pT Category (Primary Tumor) and pN Category (Regional Lymph Nodes) with Histologic Grade,N/A,0392,100,"Percentage of colon and rectum cancer resection pathology reports that include the pT category (primary tumor), the pN category (regional lymph nodes) and the histologic grade",Effective Clinical Care,Process,College of American Pathologists,-,-,X,-,-,-,-,X,-,-,-,-,-,-,-,Measure Specification Manuals
,Prostate Cancer: Avoidance of Overuse of Bone Scan for Staging Low Risk Prostate Cancer Patients,129v5,0389,102,"Percentage of patients, regardless of age, with a diagnosis of prostate cancer at low risk of recurrence receiving interstitial prostate brachytherapy, OR external beam radiotherapy to the prostate, OR radical prostatectomy, OR cryotherapy who did not have a bone scan performed at any time since diagnosis of prostate cancer",Efficiency and Cost Reduction,Process,American Medical Association-Physician Consortium for Performance Improvement,-,-,-,-,X,-,-,X,-,-,-,-,-,x,-,Measure Specification Manuals
,Prostate Cancer: Adjuvant Hormonal Therapy for High Risk or Very High Risk Prostate Cancer,N/A,0390,104,"Percentage of patients, regardless of age, with a diagnosis of prostate cancer at high or very high risk of recurrence receiving external beam radiotherapy to the prostate who were prescribed adjuvant hormonal therapy (GnRH [gonadotropin-releasing hormone] agonist or antagonist)",Effective Clinical Care,Process,American Medical Association-Physician Consortium for Performance Improvement,American Urological Association Education and Research,-,-,-,-,-,-,X,-,-,-,-,-,-,-,Measure Specification Manuals
,Adult Major Depressive Disorder (MDD): Suicide Risk Assessment,161v4,0104,107,Percentage of patients aged 18 years and older with a diagnosis of major depressive disorder (MDD) with a suicide risk assessment completed during the visit in which a new diagnosis or recurrent episode was identified,Effective Clinical Care,Process,American Medical Association-Physician Consortium for Performance Improvement,-,-,-,-,X,-,-,-,-,-,-,-,-,X,-,Measure Specification Manuals
,Rheumatoid Arthritis (RA): Disease Modifying Anti-Rheumatic Drug (DMARD) Therapy,N/A,0054,108,"Percentage of patients aged 18 years and older who were diagnosed with rheumatoid arthritis and were prescribed, dispensed, or administered at least one ambulatory prescription for a disease-modifying anti-rheumatic drug (DMARD).",Effective Clinical Care,Process,National Committee for Quality Assurance,-,-,-,-,-,-,X,-,Rheumatoid Arthritis,-,-,-,-,-,-,Measure Specification Manuals
,Osteoarthritis (OA): Function and Pain Assessment,N/A,N/A,109,Percentage of patient visits for patients aged 21 years and older with a diagnosis of osteoarthritis (OA) with assessment for function and pain,Person and Caregiver-Centered Experience and Outcomes,Process,American Academy of Orthopedic Surgeons,-,-,X,-,-,-,-,X,-,-,-,-,-,-,-,Measure Specification Manuals
,Preventive Care and Screening: Influenza Immunization ,147v5,0041,110,Percentage of patients aged 6 months and older seen for a visit between October 1 and March 31 who received an influenza immunization OR who reported previous receipt of an influenza immunization.,Community/Population Health,Process,American Medical Association-Physician Consortium for Performance Improvement,-,-,X,-,X,X,X,X,"Chronic Kidney Disease
Preventive Care
Chronic Obstructive Pulmonary Disorder
Oncology
Asthma 
Diabetes Mellitus
Heart Failure
Inflammatory Bowel Disease
Multiple Chronic Conditions ",X,X,-,-,X,-,Measure Specification Manuals
,Pneumonia Vaccination Status for Older Adults,127v4,0043,111,Percentage of patients 65 years of age and older who have ever received a pneumococcal vaccine.,Community/Population Health,Process,National Committee for Quality Assurance,-,-,X,-,X,X,X,X,"Preventive Care
Chronic Obstructive Pulmonary Disorder
Inflammatory Bowel Disease ",X,X,-,-,X,-,Measure Specification Manuals
,Breast Cancer Screening,125v4,2372,112,Percentage of women 50 through 74 years of age who had a mammogram to screen for breast cancer within 27 months,Effective Clinical Care,Process,National Committee for Quality Assurance,-,-,X,-,X,X,X,X,Preventive Care,X,X,-,-,X,-,Measure Specification Manuals
,Colorectal Cancer Screening,130v4,0034,113,Percentage of patients 50 - 75 years of age who had appropriate screening for colorectal cancer,Effective Clinical Care,Process,National Committee for Quality Assurance,-,-,X,-,X,X,X,X,Preventive Care,-,-,-,-,X,-,Measure Specification Manuals
,Antibiotic Treatment for Adults with Acute Bronchitis: Avoidance of Inappropriate Use,N/A,0058,116,Percentage of adults 18 through 64 years of age with a diagnosis of acute bronchitis who were not prescribed or dispensed an antibiotic prescription on or 3 days after the episode,Efficiency and Cost Reduction,Process,National Committee for Quality Assurance,-,-,-,-,-,-,-,X,-,-,-,-,-,-,-,Measure Specification Manuals
,Diabetes: Eye Exam,131v4,0055,117,Percentage of patients 18 - 75 years of age with diabetes who had a retinal or dilated eye exam by an eye care professional during the measurement period or a negative retinal or dilated eye exam (no evidence of retinopathy) in the 12 months prior to the measurement period,Effective Clinical Care,Process,National Committee for Quality Assurance,-,-,X,-,X,X,X,X,"Diabetes Mellitus
Diabetic Retinopathy",-,X,-,-,X,-,Measure Specification Manuals
,Coronary Artery Disease (CAD): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) Therapy -- Diabetes or Left Ventricular Systolic Dysfunction (LVEF < 40%),N/A,0066,118,Percentage of patients aged 18 years and older with a diagnosis of coronary artery disease seen within a 12 month period who also have diabetes OR a current or prior Left Ventricular Ejection Fraction (LVEF) < 40% who were prescribed ACE inhibitor or ARB therapy,Effective Clinical Care,Process,American College of Cardiology,American Heart Association,American Medical Association-Physician Consortium for Performance Improvement,-,-,-,X,-,X,-,-,X,-,-,-,-,Measure Specification Manuals
,Diabetes: Medical Attention for Nephropathy,134v4,0062,119,The percentage of patients 18-75 years of age with diabetes who had a nephropathy screening test or evidence of nephropathy during the measurement period,Effective Clinical Care,Process,National Committee for Quality Assurance,-,-,-,-,X,-,X,X,Diabetes Mellitus,-,-,-,-,X,-,Measure Specification Manuals
,Adult Kidney Disease: Laboratory Testing (Lipid Profile),N/A,N/A,121,"Percentage of patients aged 18 years and older with a diagnosis of chronic kidney disease (CKD) (stage 3, 4, or 5, not receiving Renal Replacement Therapy [RRT]) who had a fasting lipid profile performed at least once within a 12-month period",Effective Clinical Care,Process,Renal Physicians Association,-,-,-,-,-,-,X,X,Chronic Kidney Disease,-,-,-,-,-,-,Measure Specification Manuals
,Adult Kidney Disease: Blood Pressure Management,N/A,N/A,122,"Percentage of patient visits for those patients aged 18 years and older with a diagnosis of chronic kidney disease (CKD) (stage 3, 4, or 5, not receiving Renal Replacement Therapy [RRT]) with a blood pressure < 140/90 mmHg OR ≥ 140/90 mmHg with a documented plan of care",Effective Clinical Care, Intermediate Outcome,Renal Physicians Association,-,-,-,-,-,-,X,X,Chronic Kidney Disease,-,-,X,-,-,-,Measure Specification Manuals
,"Diabetes Mellitus: Diabetic Foot and Ankle Care, Peripheral Neuropathy –
Neurological Evaluation",N/A,0417,126,Percentage of patients aged 18 years and older with a diagnosis of diabetes mellitus who had a neurological examination of their lower extremities within 12 months,Effective Clinical Care,Process,American Podiatric Medical Association,-,-,-,-,-,-,X,X,Diabetes Mellitus,-,-,-,-,-,-,Measure Specification Manuals
,"Diabetes Mellitus: Diabetic Foot and Ankle Care, Ulcer Prevention – Evaluation of Footwear",N/A,0416,127,Percentage of patients aged 18 years and older with a diagnosis of diabetes mellitus who were evaluated for proper footwear and sizing,Effective Clinical Care,Process,American Podiatric Medical Association,-,-,-,-,-,-,-,X,-,-,-,-,-,-,-,Measure Specification Manuals
,Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-Up Plan,69v4,0421,128,"Percentage of patients aged 18 years and older with a BMI documented during the current encounter or during the previous six months AND with a BMI outside of normal parameters, a follow-up plan is documented during the encounter or during the previous six months of the current encounter

Normal Parameters: Age 65 years and older BMI ≥ 23 and < 30 kg/m2; Age 18 – 64 years BMI ≥ 18.5 and < 25 kg/m2",Community/Population Health,Process,Centers for Medicare & Medicaid Services,Mathematica,Quality Insights of Pennsylvania,X,-,X,X,X,X,"Preventive Care
Sleep Apnea
Asthma
Rheumatoid Arthritis
Coronary Artery Disease
Multiple Chronic Conditions
",X,X,-,-,X,-,Measure Specification Manuals
,Documentation of Current Medications in the Medical Record,68v5,0419,130,"Percentage of visits for patients aged 18 years and older for which the eligible professional attests to documenting a list of current medications using all immediate resources available on the date of the encounter. This list must include ALL known prescriptions, over-the-counters, herbals, and vitamin/mineral/dietary (nutritional) supplements AND must contain the medications’ name, dosage, frequency and route of administration.",Patient Safety,Process,Centers for Medicare & Medicaid Services,Mathematica,Quality Insights of Pennsylvania,X,-,X,X,X,X,"Chronic Kidney Disease
Oncology
Chronic Obstructive Pulmonary Disorder
Cataracts
General Surgery
Heart Failure
Hepatitis C
Sinusitis 
Sleep Apnea
Total Knee Replacement
Asthma
Acute Otitis Externa (AOE)
Coronary Artery Disease
Cardiovascular Prevention
Diabetic Retinopathy
Multiple Chronic Conditions",X,X,-,-,X,-,Measure Specification Manuals
,Pain Assessment and Follow-Up,N/A,0420,131,Percentage of visits for patients aged 18 years and older with documentation of a pain assessment using a standardized tool(s) on each visit AND documentation of a follow-up plan when pain is present,Communication and Care Coordination,Process,Centers for Medicare & Medicaid Services,Quality Insights of Pennsylvania,-,X,-,-,-,X,X,"Acute Otitis Externa (AOE)
Sinusitis 
Rheumatoid Arthritis
Multiple Chronic Conditions",X,-,-,-,-,-,Measure Specification Manuals
,Preventive Care and Screening: Screening for Clinical Depression and Follow-Up Plan,2v5,0418,134,"Percentage of patients aged 12 years and older screened for clinical depression on the date of the encounter using an age appropriate standardized depression screening tool AND if positive, a follow-up plan is documented on the date of the positive screen. ",Community/Population Health,Process,Centers for Medicare & Medicaid Services,Mathematica,Quality Insights of Pennsylvania,X,-,X,X,X,X,"Preventive Care 
HIV/AIDS 
Multiple Chronic Conditions
Dementia",X,X,-,-,X,-,Measure Specification Manuals
,Melanoma: Continuity of Care – Recall System,N/A,0650,137,"Percentage of patients, regardless of age, with a current diagnosis of melanoma or a history of melanoma whose information was entered, at least once within a 12 month period, into a recall system that includes:
 • A target date for the next complete physical skin exam, AND
 • A process to follow up with patients who either did not make an appointment within the specified timeframe or who missed a scheduled appointment",Communication and Care Coordination,Structure,American Academy of Dermatology,American Medical Association-Physician Consortium for Performance Improvement,-,-,-,-,-,-,X,-,-,-,-,-,-,-,Measure Specification Manuals
,Melanoma: Coordination of Care,N/A,N/A,138,"Percentage of patient visits, regardless of age, with a new occurrence of melanoma who have a treatment plan documented in the chart that was communicated to the physician(s) providing continuing care within one month of diagnosis",Communication and Care Coordination,Process,American Academy of Dermatology,American Medical Association-Physician Consortium for Performance Improvement,-,-,-,-,-,-,X,-,-,-,-,-,-,-,Measure Specification Manuals
,Age-Related Macular Degeneration (AMD): Counseling on Antioxidant Supplement,N/A,0566,140,Percentage of patients aged 50 years and older with a diagnosis of age-related macular degeneration (AMD) or their caregiver(s) who were counseled within 12 months on the benefits and/or risks of the Age-Related Eye Disease Study (AREDS) formulation for preventing progression of AMD,Effective Clinical Care,Process,American Academy of Ophthalmology,-,-,X,-,-,-,-,X,-,-,-,-,-,-,-,Measure Specification Manuals
,Primary Open-Angle Glaucoma (POAG): Reduction of Intraocular Pressure (IOP) by 15% OR Documentation of a Plan of Care,N/A,0563,141,"Percentage of patients aged 18 years and older with a diagnosis of primary open-angle glaucoma (POAG) whose glaucoma treatment has not failed (the most recent IOP was reduced by at least 15% from the pre- intervention level) OR if the most recent IOP was not reduced by at least 15% from the pre- intervention level, a plan of care was documented within 12 months",Communication and Care Coordination,Outcome,American Academy of Ophthalmology,-,-,X,-,-,-,-,X,-,-,-,-,-,-,-,Measure Specification Manuals
,Oncology: Medical and Radiation – Pain Intensity Quantified,157v4,0384,143,"Percentage of patient visits, regardless of patient age, with a diagnosis of cancer currently receiving chemotherapy or radiation therapy in which pain intensity is quantified",Person and Caregiver-Centered Experience and Outcomes,Process,American Medical Association-Physician Consortium for Performance Improvement,-,-,-,-,X,-,X,X,Oncology,-,-,-,-,X,-,Measure Specification Manuals
,Oncology: Medical and Radiation – Plan of Care for Pain,N/A,0383,144,"Percentage of visits for patients, regardless of age, with a diagnosis of cancer currently receiving chemotherapy or radiation therapy who report having pain with a documented plan of care to address pain",Person and Caregiver-Centered Experience and Outcomes,Process,American Society of Clinical Oncology,-,-,-,-,-,-,X,X,Oncology,-,-,-,-,-,-,Measure Specification Manuals
,Radiology: Exposure Time Reported for Procedures Using Fluoroscopy,N/A,N/A,145,"Final reports for procedures using fluoroscopy that document radiation exposure indices, or exposure time and number of fluorographic images (if radiation exposure indices are not available)",Patient Safety,Process,American College of Radiology,American Medical Association-Physician Consortium for Performance Improvement,-,X,-,-,-,-,X,-,-,-,-,-,-,-,Measure Specification Manuals
,Radiology: Inappropriate Use of “Probably Benign” Assessment Category in Mammography Screening,N/A,0508,146,Percentage of final reports for screening mammograms that are classified as “probably benign”,Efficiency and Cost Reduction,Process,American College of Radiology,American Medical Association-Physician Consortium for Performance Improvement,-,X,-,-,-,-,X,-,-,-,-,-,-,-,Measure Specification Manuals
,Nuclear Medicine: Correlation with Existing Imaging Studies for All Patients Undergoing Bone Scintigraphy,N/A,N/A,147,"Percentage of final reports for all patients, regardless of age, undergoing bone scintigraphy that include physician documentation of correlation with existing relevant imaging studies (e.g., x-ray, MRI, CT, etc.) that were performed",Communication and Care Coordination,Process,American Medical Association-Physician Consortium for Performance Improvement,Society of Nuclear Medicine and Molecular Imaging,-,X,-,-,-,-,X,-,-,-,-,-,-,-,Measure Specification Manuals
,Falls: Risk Assessment,N/A,0101,154,Percentage of patients aged 65 years and older with a history of falls who had a risk assessment for falls completed within 12 months,Patient Safety,Process,National Committee for Quality Assurance,American Medical Association-Physician Consortium for Performance Improvement,-,X,-,-,-,X,X,"Acute Otitis Externa (AOE)
Multiple Chronic Conditions",X,-,-,-,-,-,Measure Specification Manuals
,Falls: Plan of Care,N/A,0101,155,Percentage of patients aged 65 years and older with a history of falls who had a plan of care for falls documented within 12 months,Communication and Care Coordination,Process,National Committee for Quality Assurance,American Medical Association-Physician Consortium for Performance Improvement,-,X,-,-,-,X,X,"Acute Otitis Externa (AOE)
Multiple Chronic Conditions",X,-,-,-,-,-,Measure Specification Manuals
,Oncology: Radiation Dose Limits to Normal Tissues,N/A,0382,156,"Percentage of patients, regardless of age, with a diagnosis of breast, rectal, pancreatic or lung cancer receiving 3D conformal radiation therapy who had documentation in medical record that radiation dose limits to normal tissues were established prior to the initiation of a course of 3D conformal radiation for a minimum of two tissues.",Patient Safety,Process,American Society for Radiation Oncology,-,-,X,-,-,-,-,X,-,-,-,-,-,-,-,Measure Specification Manuals
,HIV/AIDS: Pneumocystis Jiroveci Pneumonia (PCP) Prophylaxis,52v4,0405,160,Percentage of patients aged 6 weeks and older with a diagnosis of HIV/AIDS who were prescribed Pneumocystis Jiroveci Pneumonia (PCP) prophylaxis,Effective Clinical Care,Process,National Committee for Quality Assurance,-,-,-,-,X,-,X,-,HIV/AIDS,-,-,-,-,X,-,Measure Specification Manuals
,Diabetes: Foot Exam,123v4,0056,163,Percentage of patients aged 18-75 years of age with diabetes who had a foot exam during the measurement period,Effective Clinical Care,Process,National Committee for Quality Assurance,-,-,-,-,X,-,-,-,-,-,X,-,-,X,-,Measure Specification Manuals
,Coronary Artery Bypass Graft (CABG): Prolonged Intubation,N/A,0129,164,Percentage of patients aged 18 years and older undergoing isolated CABG surgery who require postoperative intubation > 24 hours,Effective Clinical Care,Outcome,Society of Thoracic Surgeons,-,-,-,-,-,-,X,X,Coronary Artery Bypass Graft,-,-,-,-,-,-,Measure Specification Manuals
,Coronary Artery Bypass Graft (CABG): Deep Sternal Wound Infection Rate,N/A,0130,165,"Percentage of patients aged 18 years and older undergoing isolated CABG surgery who, within 30 days postoperatively, develop deep sternal wound infection involving muscle, bone, and/or mediastinum requiring operative intervention",Effective Clinical Care,Outcome,Society of Thoracic Surgeons,-,-,-,-,-,-,X,-,Coronary Artery Bypass Graft,-,-,-,-,-,-,Measure Specification Manuals
,Coronary Artery Bypass Graft (CABG): Stroke,N/A,0131,166,"Percentage of patients aged 18 years and older undergoing isolated CABG surgery who have a postoperative stroke (i.e., any confirmed neurological deficit of abrupt onset caused by a disturbance in blood supply to the brain) that did not resolve within 24 hours",Effective Clinical Care,Outcome,Society of Thoracic Surgeons,-,-,-,-,-,-,X,-,Coronary Artery Bypass Graft,-,-,-,-,-,-,Measure Specification Manuals
,Coronary Artery Bypass Graft (CABG): Postoperative Renal Failure,N/A,0114,167,Percentage of patients aged 18 years and older undergoing isolated CABG surgery (without pre-existing renal failure) who develop postoperative renal failure or require dialysis,Effective Clinical Care,Outcome,Society of Thoracic Surgeons,-,-,-,-,-,-,X,-,Coronary Artery Bypass Graft,-,-,-,-,-,-,Measure Specification Manuals
,Coronary Artery Bypass Graft (CABG): Surgical Re-Exploration,N/A,0115,168,"Percentage of patients aged 18 years and older undergoing isolated CABG surgery who require a return to the operating room (OR) during the current hospitalization for mediastinal bleeding with or without tamponade, graft occlusion, valve dysfunction, or other cardiac reason",Effective Clinical Care,Outcome,Society of Thoracic Surgeons,-,-,-,-,-,-,X,-,Coronary Artery Bypass Graft,-,-,-,-,-,-,Measure Specification Manuals
,Rheumatoid Arthritis (RA): Tuberculosis Screening,N/A,N/A,176,Percentage of patients aged 18 years and older with a diagnosis of rheumatoid arthritis (RA) who have documentation of a tuberculosis (TB) screening performed and results interpreted within 6 months prior to receiving a first course of therapy using a biologic disease-modifying anti-rheumatic drug (DMARD),Effective Clinical Care,Process,American College of Rheumatology,-,-,-,-,-,-,X,-,Rheumatoid Arthritis,-,-,X,-,-,-,Measure Specification Manuals
,Rheumatoid Arthritis (RA): Periodic Assessment of Disease Activity,N/A,N/A,177,Percentage of patients aged 18 years and older with a diagnosis of rheumatoid arthritis (RA) who have an assessment and classification of disease activity within 12 months,Effective Clinical Care,Process,American College of Rheumatology,-,-,-,-,-,-,X,-,Rheumatoid Arthritis,-,-,X,-,-,-,Measure Specification Manuals
,Rheumatoid Arthritis (RA): Functional Status Assessment,N/A,N/A,178,Percentage of patients aged 18 years and older with a diagnosis of rheumatoid arthritis (RA) for whom a functional status assessment was performed at least once within 12 months,Effective Clinical Care,Process,American College of Rheumatology,,,-,-,-,-,X,X,Rheumatoid Arthritis,-,-,X,-,-,-,Measure Specification Manuals
,Rheumatoid Arthritis (RA): Assessment and Classification of Disease Prognosis,N/A,N/A,179,Percentage of patients aged 18 years and older with a diagnosis of rheumatoid arthritis (RA) who have an assessment and classification of disease prognosis at least once within 12 months,Effective Clinical Care,Process,American College of Rheumatology,-,-,-,-,-,-,X,-,Rheumatoid Arthritis,-,-,X,-,-,-,Measure Specification Manuals
,Rheumatoid Arthritis (RA): Glucocorticoid Management,N/A,N/A,180,"Percentage of patients aged 18 years and older with a diagnosis of rheumatoid arthritis (RA) who have been assessed for glucocorticoid use and, for those on prolonged doses of prednisone ≥ 10 mg daily (or equivalent) with improvement or no change in disease activity, documentation of glucocorticoid management plan within 12 months",Effective Clinical Care,Process,American College of Rheumatology,-,-,-,-,-,-,X,-,Rheumatoid Arthritis,-,-,X,-,-,-,Measure Specification Manuals
,Elder Maltreatment Screen and Follow-Up Plan,N/A,N/A,181,Percentage of patients aged 65 years and older with a documented elder maltreatment screen using an Elder Maltreatment Screening Tool on the date of encounter AND a documented follow-up plan on the date of the positive screen,Patient Safety,Process,Centers for Medicare & Medicaid Services,Quality Insights of Pennsylvania,-,X,-,-,-,-,X,-,-,-,X,-,-,-,Measure Specification Manuals
,Functional Outcome Assessment,N/A,2624,182,Percentage of visits for patients aged 18 years and older with documentation of a current functional outcome assessment using a standardized functional outcome assessment tool on the date of encounter AND documentation of a care plan based on identified functional outcome deficiencies on the date of the identified deficiencies.,Communication and Care Coordination,Process,Centers for Medicare & Medicaid Services,Quality Insights of Pennsylvania,-,X,-,-,-,-,X,-,X,-,X,-,-,-,Measure Specification Manuals
,Hepatitis C: Hepatitis A Vaccination,N/A,0399,183,"Percentage of patients aged 18 years and older with a diagnosis of chronic hepatitis C who have received at least one injection of hepatitis A vaccine, or who have documented immunity to hepatitis A",Community/Population Health,Process,American Medical Association-Physician Consortium for Performance Improvement,American Gastroenterological Association,-,-,-,-,-,X,-,Hepatitis C,-,-,-,-,-,-,Measure Specification Manuals
,Colonoscopy Interval for Patients with a History of Adenomatous Polyps – Avoidance of Inappropriate Use,N/A,0659,185,"Percentage of patients aged 18 years and older receiving a surveillance colonoscopy, with a history of a prior adenomatous polyp(s) in previous colonoscopy findings, who had an interval of 3 or more years since their last colonoscopy",Communication and Care Coordination,Process,American Medical Association-Physician Consortium for Performance Improvement,American Gastroenterological Association,"American Society for Gastrointestinal Endoscopy/ American College of Gastroenterology
",X,-,-,-,-,X,-,-,-,-,-,-,-,Measure Specification Manuals
,Stroke and Stroke Rehabilitation: Thrombolytic Therapy,N/A,N/A,187,Percentage of patients aged 18 years and older with a diagnosis of acute ischemic stroke who arrive at the hospital within two hours of time last known well and for whom IV t-PA was initiated within three hours of time last known well,Effective Clinical Care,Outcome,American Heart Association,American Society of Anesthesiologists,The Joint Commission,-,-,-,-,-,X,-,-,-,-,-,-,-,Measure Specification Manuals
,Cataracts: 20/40 or Better Visual Acuity within 90 Days Following Cataract Surgery,133v4,0565,191,Percentage of patients aged 18 years and older with a diagnosis of uncomplicated cataract who had cataract surgery and no significant ocular conditions impacting the visual outcome of surgery and had best-corrected visual acuity of 20/40 or better (distance or near) achieved within 90 days following the cataract surgery,Effective Clinical Care,Outcome,American Medical Association-Physician Consortium for Performance Improvement,National Committee for Quality Assurance,-,-,-,X,-,X,X,Cataracts,-,-,-,-,X,-,Measure Specification Manuals
,Cataracts: Complications within 30 Days Following Cataract Surgery Requiring Additional Surgical Procedures,132v4,0564,192,"Percentage of patients aged 18 years and older with a diagnosis of uncomplicated cataract who had cataract surgery and had any of a specified list of surgical procedures in the 30 days following cataract surgery which would indicate the occurrence of any of the following major complications: retained nuclear fragments, endophthalmitis, dislocated or wrong power IOL, retinal detachment, or wound dehiscence",Patient Safety,Outcome,American Medical Association-Physician Consortium for Performance Improvement,National Committee for Quality Assurance,-,-,-,X,-,X,X,Cataracts,-,-,-,-,X,-,Measure Specification Manuals
,Radiology: Stenosis Measurement in Carotid Imaging Reports,N/A,0507,195,"Percentage of final reports for carotid imaging studies (neck magnetic resonance angiography [MRA], neck computed tomography angiography [CTA], neck duplex ultrasound, carotid angiogram) performed that include direct or indirect reference to measurements of distal internal carotid diameter as the denominator for stenosis measurement",Effective Clinical Care,Process,American College of Radiology,American Medical Association-Physician Consortium for Performance Improvement,-,X,-,-,-,-,X,-,-,-,-,-,-,-,Measure Specification Manuals
,Ischemic Vascular Disease (IVD): Use of Aspirin or Another Antithrombotic,164v4,0068,204,"Percentage of patients 18 years of age and older who were discharged alive for acute myocardial infarction (AMI), coronary artery bypass graft (CABG) or percutaneous coronary interventions (PCI) in the 12 months prior to the measurement period, or who had an active diagnosis of ischemic vascular disease (IVD) during the measurement period and who had documentation of use of aspirin or another antithrombotic during the measurement period",Effective Clinical Care,Process,National Committee for Quality Assurance,-,-,X,-,X,X,X,X,Cardiovascular Prevention,-,-,-,-,X,X,Measure Specification Manuals
,"HIV/AIDS: Sexually Transmitted Disease Screening for Chlamydia, Gonorrhea, and Syphilis",N/A,0409,205,"Percentage of patients aged 13 years and older with a diagnosis of HIV/AIDS for whom chlamydia, gonorrhea and syphilis screenings were performed at least once since the diagnosis of HIV infection ",Effective Clinical Care,Process,National Committee for Quality Assurance,American Medical Association-Physician Consortium for Performance Improvement,-,-,-,-,-,X,X,HIV/AIDS,-,-,-,-,-,-,Measure Specification Manuals
,Functional Deficit: Change in Risk-Adjusted Functional Status for Patients with Knee Impairments,N/A,0422,217,Percentage of patients aged 18 or older that receive treatment for a functional deficit secondary to a diagnosis that affects the knee in which the change in their Risk-Adjusted Functional Status is measured,Communication and Care Coordination,Process,"Focus on Therapeutic Outcomes, Inc.",-,-,-,-,-,-,-,X,-,-,-,-,-,-,-,Measure Specification Manuals
,Functional Deficit: Change in Risk-Adjusted Functional Status for Patients with Hip Impairments,N/A,0423,218,Percentage of patients aged 18 or older that receive treatment for a functional deficit secondary to a diagnosis that affects the hip in which the change in their Risk-Adjusted Functional Status is measured,Communication and Care Coordination,Outcome,"Focus on Therapeutic Outcomes, Inc.",-,-,-,-,-,-,-,X,-,-,-,-,-,-,-,Measure Specification Manuals
,"Functional Deficit: Change in Risk-Adjusted Functional Status for Patients with Lower Leg, Foot or Ankle Impairments",N/A,0424,219,"Percentage of patients aged 18 or older that receive treatment for a functional deficit secondary to a diagnosis that affects the lower leg, foot or ankle in which the change in their Risk-Adjusted Functional Status is measured",Communication and Care Coordination,Outcome,"Focus on Therapeutic Outcomes, Inc.",-,-,-,-,-,-,-,X,-,-,-,-,-,-,-,Measure Specification Manuals
,Functional Deficit: Change in Risk-Adjusted Functional Status for Patients with Lumbar Spine Impairments,N/A,0425,220,Percentage of patients aged 18 or older that receive treatment for a functional deficit secondary to a diagnosis that affects the lumbar spine in which the change in their Risk-Adjusted Functional Status is measured,Communication and Care Coordination,Outcome,"Focus on Therapeutic Outcomes, Inc.",-,-,-,-,-,-,-,X,-,-,-,-,-,-,-,Measure Specification Manuals
,Functional Deficit: Change in Risk-Adjusted Functional Status for Patients with Shoulder Impairments,N/A,0426,221,Percentage of patients aged 18 or older that receive treatment for a functional deficit secondary to a diagnosis that affects the shoulder in which the change in their Risk-Adjusted Functional Status is measured,Communication and Care Coordination,Outcome,"Focus on Therapeutic Outcomes, Inc.",-,-,-,-,-,-,-,X,-,-,-,-,-,-,-,Measure Specification Manuals
,"Functional Deficit: Change in Risk-Adjusted Functional Status for Patients with Elbow, Wrist or Hand Impairments",N/A,0427,222,"Percentage of patients aged 18 or older that receive treatment for a functional deficit secondary to a diagnosis that affects the elbow, wrist or hand in which the change in their Risk-Adjusted Functional Status is measured",Communication and Care Coordination,Outcome,"Focus on Therapeutic Outcomes, Inc.",-,-,-,-,-,-,-,X,-,-,-,-,-,-,-,Measure Specification Manuals
,"Functional Deficit: Change in Risk-Adjusted Functional Status for Patients with Neck, Cranium, Mandible, Thoracic Spine, Ribs, or Other General Orthopedic Impairments",N/A,0428,223,"Percentage of patients aged 18 or older that receive treatment for a functional deficit secondary to a diagnosis that affects the neck, cranium, mandible, thoracic spine, ribs, or other general orthopedic impairment in which the change in their Risk-Adjusted Functional Status is measured",Communication and Care Coordination,Outcome,"Focus on Therapeutic Outcomes, Inc.",-,-,-,-,-,-,-,X,-,-,-,-,-,-,-,Measure Specification Manuals
,Melanoma: Overutilization of Imaging Studies in Melanoma,N/A,0562,224,"Percentage of patients, regardless of age, with a current diagnosis of stage 0 through IIC melanoma or a history of melanoma of any stage, without signs or symptoms suggesting systemic spread, seen for an office visit during the one-year measurement period, for whom no diagnostic imaging studies were ordered",Efficiency and Cost Reduction,Process,American Academy of Dermatology,American Medical Association-Physician Consortium for Performance Improvement,-,-,-,-,-,-,X,-,-,-,-,-,-,-,Measure Specification Manuals
,Radiology: Reminder System for Screening Mammograms,N/A,0509,225,Percentage of patients undergoing a screening mammogram whose information is entered into a reminder system with a target due date for the next mammogram,Communication and Care Coordination,Structure,American College of Radiology,American Medical Association-Physician Consortium for Performance Improvement,-,X,-,-,-,-,X,-,-,-,-,-,-,-,Measure Specification Manuals
,Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention,138v4,0028,226,Percentage of patients aged 18 years and older who were screened for tobacco use one or more times within 24 months AND who received cessation counseling intervention if identified as a tobacco user.,Community/Population Health,Process,American Medical Association-Physician Consortium for Performance Improvement,-,-,X,-,X,X,X,X,"Preventive Care
Heart Failure
Coronary Artery Disease
Chronic Obstructive Pulmonary Disease
Inflammatory Bowel Disease
Asthma
Oncology
Chronic Kidney Disease
Cataracts
Diabetic Mellitus
General Surgery
Hepatitis C
HIV/AIDS
Sinusitis 
Sleep Apnea
Total Knee Replacement
Acute Otitis Externa (AOE)
Cardiovascular Prevention
Diabetic Retinopathy",X,X,-,-,X,X,Measure Specification Manuals
,Controlling High Blood Pressure,165v4,0018,236,Percentage of patients 18-85 years of age who had a diagnosis of hypertension and whose blood pressure was adequately controlled (<140/90 mmHg) during the measurement period,Effective Clinical Care, Intermediate Outcome,National Committee for Quality Assurance,-,-,X,-,X,X,X,X,Cardiovascular Prevention,X,X,-,-,X,X,Measure Specification Manuals
,Use of High-Risk Medications in the Elderly,156v4,0022,238,"Percentage of patients 66 years of age and older who were ordered high-risk medications. Two rates are reported.
a. Percentage of patients who were ordered at least one high-risk medication. 
b. Percentage of patients who were ordered at least two different high-risk medications.",Patient Safety,Process,National Committee for Quality Assurance,-,-,-,-,X,-,X,X,Multiple Chronic Conditions,-,-,-,-,X,-,Measure Specification Manuals
,Weight Assessment and Counseling for Nutrition and Physical Activity for Children and Adolescents,155v4,0024,239,"Percentage of patients 3-17 years of age who had an outpatient visit with a Primary Care Physician (PCP) or Obstetrician/Gynecologist (OB/GYN) and who had evidence of the following during the measurement period. Three rates are reported.
 - Percentage of patients with height, weight, and body mass index (BMI) percentile documentation
 - Percentage of patients with counseling for nutrition
 - Percentage of patients with counseling for physical activity",Community/Population Health,Process,National Committee for Quality Assurance,-,-,-,-,X,-,-,-,-,-,-,-,-,X,-,Measure Specification Manuals
,Childhood Immunization Status,117v4,0038,240,"Percentage of children 2 years of age who had four diphtheria, tetanus and acellular pertussis (DTaP); three polio (IPV), one measles, mumps and rubella (MMR); three H influenza type B (HiB); three hepatitis B (Hep B); one chicken pox (VZV); four pneumococcal conjugate (PCV); one hepatitis A (Hep A); two or three rotavirus (RV); and two influenza (flu) vaccines by their second birthday.",Community/Population Health,Process,National Committee for Quality Assurance,-,-,-,-,X,-,-,-,-,X,-,-,-,X,-,Measure Specification Manuals
,Ischemic Vascular Disease (IVD): Complete Lipid Profile and LDL-C Control (< 100 mg/dL),182v5,N/A,241,"Percentage of patients 18 years of age and older who were discharged alive for acute myocardial infarction (AMI), coronary artery bypass graft (CABG) or percutaneous coronary interventions (PCI) in the 12 months prior to the measurement period, or who had an active diagnosis of ischemic vascular disease (IVD) during the measurement period, and who had each of the following during the measurement period: a complete lipid profile and LDL-C was adequately controlled (< 100 mg/dL)",Effective Clinical Care, Intermediate Outcome,National Committee for Quality Assurance,-,-,-,-,X,-,-,-,-,-,-,-,-,X,X,Measure Specification Manuals
,Coronary Artery Disease (CAD): Symptom Management,N/A,N/A,242,Percentage of patients aged 18 years and older with a diagnosis of coronary artery disease (CAD) seen within a 12 month period with results of an evaluation of level of activity and an assessment of whether anginal symptoms are present or absent with appropriate management of anginal symptoms within a 12 month period,Effective Clinical Care,Outcome,American College of Cardiology,American Heart Association,American Medical Association-Physician Consortium for Performance Improvement,-,-,-,-,X,-,Coronary Artery Disease,-,-,-,-,-,-,Measure Specification Manuals
,Cardiac Rehabilitation Patient Referral from an Outpatient Setting,N/A,0643,243,"Percentage of patients evaluated in an outpatient setting who within the previous 12 months have experienced an acute myocardial infarction (MI), coronary artery bypass graft (CABG) surgery, a percutaneous coronary intervention (PCI), cardiac valve surgery, or cardiac transplantation, or who have chronic stable angina (CSA) and have not already participated in an early outpatient cardiac rehabilitation/secondary prevention (CR) program for the qualifying event/diagnosis who were referred to a CR program",Communication and Care Coordination,Process,American College of Cardiology Foundation,American Heart Association,-,-,-,-,-,-,X,-,-,-,-,-,-,-,Measure Specification Manuals
,Barrett's Esophagus,N/A,1854,249,Percentage of esophageal biopsy reports that document the presence of Barrett’s mucosa that also include a statement about dysplasia,Effective Clinical Care,Structure,College of American Pathologists,-,-,X,-,-,-,-,X,-,-,-,-,-,-,-,Measure Specification Manuals
,Radical Prostatectomy Pathology Reporting,N/A,1853,250,"Percentage of radical prostatectomy pathology reports that include the pT category, the pN category, the Gleason score and a statement about margin status",Effective Clinical Care,Structure,College of American Pathologists,-,-,X,-,-,-,-,X,-,-,-,-,-,-,-,Measure Specification Manuals
,Quantitative Immunohistochemical (IHC) Evaluation of Human Epidermal Growth Factor Receptor 2 Testing (HER2) for Breast Cancer Patients,N/A,1855,251,This is a measure based on whether quantitative evaluation of Human Epidermal Growth Factor Receptor 2 Testing (HER2) by immunohistochemistry (IHC) uses the system recommended in the current ASCO/CAP Guidelines for Human Epidermal Growth Factor Receptor 2 Testing in breast cancer,Effective Clinical Care,Structure,College of American Pathologists,-,-,X,-,-,-,-,X,-,-,-,-,-,-,-,Measure Specification Manuals
,"Ultrasound Determination of Pregnancy Location for Pregnant Patients with
Abdominal Pain",N/A,0651,254,Percentage of pregnant female patients aged 14 to 50 who present to the emergency department (ED) with a chief complaint of abdominal pain or vaginal bleeding who receive a trans-abdominal or trans-vaginal ultrasound to determine pregnancy location,Effective Clinical Care,Process,American College of Emergency Physicians,-,-,X,-,-,-,-,X,-,-,-,-,-,-,-,Measure Specification Manuals
,Rh Immunoglobulin (Rhogam) for Rh-Negative Pregnant Women at Risk of Fetal Blood Exposure,N/A,N/A,255,Percentage of Rh-negative pregnant women aged 14-50 years at risk of fetal blood exposure who receive Rh-Immunoglobulin (Rhogam) in the emergency department (ED),Effective Clinical Care,Process,American College of Emergency Physicians,-,-,X,-,-,-,-,X,-,-,-,-,-,-,-,Measure Specification Manuals
,Statin Therapy at Discharge after Lower Extremity Bypass (LEB),N/A,1519,257,Percentage of patients aged 18 years and older undergoing infra-inguinal lower extremity bypass who are prescribed a statin medication at discharge,Effective Clinical Care,Process,Society for Vascular Surgeons,-,-,-,-,-,-,-,X,-,-,-,-,-,-,-,Measure Specification Manuals
,Rate of Open Repair of Small or Moderate Non-Ruptured Abdominal Aortic Aneurysms (AAA) without Major Complications (Discharged to Home by Post-Operative Day #7),N/A,N/A,258,Percent of patients undergoing open repair of small or moderate sized non-ruptured abdominal aortic aneurysms who do not experience a major complication (discharge to home no later than post-operative day #7),Patient Safety,Outcome,Society for Vascular Surgeons,-,-,-,-,-,-,-,X,-,-,-,-,-,-,-,Measure Specification Manuals
,Rate of Endovascular Aneurysm Repair (EVAR) of Small or Moderate Non-Ruptured Abdominal Aortic Aneurysms (AAA) without Major Complications (Discharged to Home by Post-Operative Day #2),N/A,N/A,259,Percent of patients undergoing endovascular repair of small or moderate non-ruptured abdominal aortic aneurysms (AAA) that do not experience a major complication (discharged to home no later than post-operative day #2),Patient Safety,Outcome,Society for Vascular Surgeons,-,-,-,-,-,-,-,X,-,-,-,-,-,-,-,Measure Specification Manuals
,"Rate of Carotid Endarterectomy (CEA) for Asymptomatic Patients, without Major Complications (Discharged to Home by Post-Operative Day #2)",N/A,N/A,260,Percent of asymptomatic patients undergoing CEA who are discharged to home no later than post-operative day #2,Patient Safety,Outcome,Society for Vascular Surgeons,-,-,-,-,-,-,-,X,-,-,-,-,-,-,-,Measure Specification Manuals
,Referral for Otologic Evaluation for Patients with Acute or Chronic Dizziness,N/A,N/A,261,Percentage of patients aged birth and older referred to a physician (preferably a physician specially trained in disorders of the ear) for an otologic evaluation subsequent to an audiologic evaluation after presenting with acute or chronic dizziness,Communication and Care Coordination,Process,Audiology Quality Consortium,-,-,X,-,-,-,-,X,-,-,-,-,-,-,-,Measure Specification Manuals
,Image Confirmation of Successful Excision of Image–Localized Breast Lesion,N/A,N/A,262,"Image confirmation of lesion(s) targeted for image guided excisional biopsy or image guided partial mastectomy in patients with nonpalpable, image-detected breast lesion(s). Lesions may include: microcalcifications, mammographic or sonographic mass or architectural distortion, focal suspicious abnormalities on magnetic resonance imaging (MRI) or other breast imaging amenable to localization such as positron emission tomography (PET) mammography, or a biopsy marker demarcating site of confirmed pathology as established by previous core biopsy",Patient Safety,Process,American Society of Breast Surgeons,-,-,-,-,-,-,-,X,-,-,-,-,-,-,-,Measure Specification Manuals
,Preoperative Diagnosis of Breast Cancer,N/A,N/A,263,The percent of patients undergoing breast cancer operations who obtained the diagnosis of breast cancer preoperatively by a minimally invasive biopsy method ,Effective Clinical Care,Process,American Society of Breast Surgeons,-,-,-,-,-,-,-,X,-,-,-,-,-,-,-,Measure Specification Manuals
,Sentinel Lymph Node Biopsy for Invasive Breast Cancer,N/A,N/A,264,The percentage of clinically node negative (clinical stage T1N0M0 or T2N0M0) breast cancer patients who undergo a sentinel lymph node (SLN) procedure,Effective Clinical Care,Process,American Society of Breast Surgeons,-,-,-,-,-,-,-,X,-,-,-,-,-,-,-,Measure Specification Manuals
,Biopsy Follow-Up,N/A,N/A,265,Percentage of new patients whose biopsy results have been reviewed and communicated to the primary care/referring physician and patient by the performing physician,Communication and Care Coordination,Process,American Academy of Dermatology,-,-,-,-,-,-,-,X,-,-,-,-,-,-,-,Measure Specification Manuals
,Epilepsy: Counseling for Women of Childbearing Potential with Epilepsy,N/A,1814,268,All female patients of childbearing potential (12 - 44 years old) diagnosed with epilepsy who were counseled or referred for counseling for how epilepsy and its treatment may affect contraception OR pregnancy at least once a year,Effective Clinical Care,Outcome,American Academy of Neurology,-,-,X,-,-,-,-,X,-,-,-,-,-,-,-,Measure Specification Manuals
,Inflammatory Bowel Disease (IBD): Preventive Care: Corticosteroid Sparing Therapy,N/A,N/A,270,Percentage of patients aged 18 years and older with a diagnosis of inflammatory bowel disease who have been managed by corticosteroids greater than or equal to 10 mg/day of prednisone equivalents for 60 or greater consecutive days or a single prescription equating to 600 mg prednisone or greater for all fills that have been prescribed corticosteroid sparing therapy within the last twelve months,Effective Clinical Care,Outcome,American Gastroenterological Association,-,-,-,-,-,-,X,X,Inflammatory Bowel Disease,-,-,-,-,-,-,Measure Specification Manuals
,Inflammatory Bowel Disease (IBD): Preventive Care: Corticosteroid Related Iatrogenic Injury – Bone Loss Assessment,N/A,N/A,271,Percentage of patients aged 18 years and older with an inflammatory bowel disease encounter who were prescribed prednisone equivalents greater than or equal to 10 mg/day for 60 or greater consecutive days or a single prescription equating to 600mg prednisone or greater for all fills and were documented for risk of bone loss once during the reporting year or the previous calendar year,Effective Clinical Care,Process,American Gastroenterological Association,-,-,-,-,-,-,X,X,Inflammatory Bowel Disease,-,-,-,-,-,-,Measure Specification Manuals
,Inflammatory Bowel Disease (IBD): Testing for Latent Tuberculosis (TB) Before Initiating Anti-TNF (Tumor Necrosis Factor) Therapy,N/A,N/A,274,Percentage of patients aged 18 years and older with a diagnosis of inflammatory bowel disease (IBD) for whom a tuberculosis (TB) screening was performed and results interpreted within six months prior to receiving a first course of anti-TNF (tumor necrosis factor) therapy,Effective Clinical Care,Process,American Gastroenterological Association,,-,-,-,-,-,X,X,Inflammatory Bowel Disease,-,-,-,-,-,-,Measure Specification Manuals
,Inflammatory Bowel Disease (IBD): Assessment of Hepatitis B Virus (HBV) Status Before Initiating Anti-TNF (Tumor Necrosis Factor) Therapy,N/A,N/A,275,Percentage of patients aged 18 years and older with a diagnosis of inflammatory bowel disease (IBD) who had Hepatitis B Virus (HBV) status assessed and results interpreted within one year prior to receiving a first course of anti-TNF (tumor necrosis factor) therapy,Effective Clinical Care,Process,American Gastroenterological Association,-,-,-,-,-,-,X,X,Inflammatory Bowel Disease,-,-,-,-,-,-,Measure Specification Manuals
,Sleep Apnea: Assessment of Sleep Symptoms,N/A,N/A,276,"Percentage of visits for patients aged 18 years and older with a diagnosis of obstructive sleep apnea that includes documentation of an assessment of sleep symptoms, including presence or absence of snoring and daytime sleepiness",Effective Clinical Care,Process,American Academy of Sleep Medicine,American Medical Association-Physician Consortium for Performance Improvement,-,-,-,-,-,X,-,Sleep Apnea,-,-,-,-,-,-,Measure Specification Manuals
,Sleep Apnea: Severity Assessment at Initial Diagnosis,N/A,N/A,277,Percentage of patients aged 18 years and older with a diagnosis of obstructive sleep apnea who had an apnea hypopnea index (AHI) or a respiratory disturbance index (RDI) measured at the time of initial diagnosis,Effective Clinical Care,Process,American Academy of Sleep Medicine,American Medical Association-Physician Consortium for Performance Improvement,-,-,-,-,-,X,-,Sleep Apnea,-,-,-,-,-,-,Measure Specification Manuals
,Sleep Apnea: Positive Airway Pressure Therapy Prescribed,N/A,N/A,278,Percentage of patients aged 18 years and older with a diagnosis of moderate or severe obstructive sleep apnea who were prescribed positive airway pressure therapy,Effective Clinical Care,Process,American Academy of Sleep Medicine,American Medical Association-Physician Consortium for Performance Improvement,-,-,-,-,-,X,-,Sleep Apnea,-,-,-,-,-,-,Measure Specification Manuals
,Sleep Apnea: Assessment of Adherence to Positive Airway Pressure Therapy,N/A,N/A,279,Percentage of visits for patients aged 18 years and older with a diagnosis of obstructive sleep apnea who were prescribed positive airway pressure therapy who had documentation that adherence to positive airway pressure therapy was objectively measured,Effective Clinical Care,Process,American Academy of Sleep Medicine,American Medical Association-Physician Consortium for Performance Improvement,-,-,-,-,-,X,-,Sleep Apnea,-,-,-,-,-,-,Measure Specification Manuals
,Dementia: Staging of Dementia,N/A,N/A,280,"Percentage of patients, regardless of age, with a diagnosis of dementia whose severity of dementia was classified as mild, moderate or severe at least once within a 12 month period",Effective Clinical Care,Process,American Academy of Neurology,American Psychiatric Association,-,-,-,-,-,X,-,Dementia,-,-,-,-,-,-,Measure Specification Manuals
,Dementia: Cognitive Assessment,149v4,N/A,281,"Percentage of patients, regardless of age, with a diagnosis of dementia for whom an assessment of cognition is performed and the results reviewed at least once within a 12 month period",Effective Clinical Care,Process,American Medical Association-Physician Consortium for Performance Improvement,-,-,-,-,X,-,X,-,Dementia,-,-,-,-,-,-,Measure Specification Manuals
,Dementia: Functional Status Assessment,N/A,N/A,282,"Percentage of patients, regardless of age, with a diagnosis of dementia for whom an assessment of functional status is performed and the results reviewed at least once within a 12 month period",Effective Clinical Care,Process,American Academy of Neurology,American Psychiatric Association,-,-,-,-,-,X,-,Dementia,-,-,-,-,-,-,Measure Specification Manuals
,Dementia: Neuropsychiatric Symptom Assessment,N/A,N/A,283,"Percentage of patients, regardless of age, with a diagnosis of dementia and for whom an assessment of  neuropsychiatric symptoms is performed and results reviewed at least once in a 12 month period",Effective Clinical Care,Process,American Academy of Neurology,American Psychiatric Association,-,-,-,-,-,X,-,Dementia,-,-,-,-,-,-,Measure Specification Manuals
,Dementia: Management of Neuropsychiatric Symptoms,N/A,N/A,284,"Percentage of patients, regardless of age, with a diagnosis of dementia who have one or more neuropsychiatric symptoms who received or were recommended to receive an intervention for neuropsychiatric symptoms within a 12 month period",Effective Clinical Care,Process,American Academy of Neurology,American Psychiatric Association,-,-,-,-,-,X,-,Dementia,-,-,-,-,-,-,Measure Specification Manuals
,Dementia: Counseling Regarding Safety Concerns,N/A,N/A,286,"Percentage of patients, regardless of age, with a diagnosis of dementia or their caregiver(s) who were counseled or referred for counseling regarding safety concerns within a 12 month period",Patient Safety,Process,American Academy of Neurology,American Psychiatric Association,-,-,-,-,-,X,-,Dementia,-,-,-,-,-,-,Measure Specification Manuals
,Dementia: Counseling Regarding Risks of Driving,N/A,N/A,287,"Percentage of patients, regardless of age, with a diagnosis of dementia or their caregiver(s) who were counseled regarding the risks of driving and the alternatives to driving at least once within a 12 month period",Effective Clinical Care,Process,American Academy of Neurology,American Psychiatric Association,-,-,-,-,-,X,-,Dementia,-,-,-,-,-,-,Measure Specification Manuals
,Dementia: Caregiver Education and Support,N/A,N/A,288,"Percentage of patients, regardless of age, with a diagnosis of dementia whose caregiver(s) were provided with education on dementia disease management and health behavior changes AND referred to additional sources for support within a 12 month period",Communication and Care Coordination,Process,American Academy of Neurology,American Psychiatric Association,-,-,-,-,-,X,-,Dementia,-,-,-,-,-,-,Measure Specification Manuals
,Parkinson’s Disease: Annual Parkinson’s Disease Diagnosis Review,N/A,N/A,289,"All patients with a diagnosis of Parkinson’s disease who had an annual assessment including a review of current medications (e.g., medications that can produce Parkinson-like signs or symptoms) and a review for the presence of atypical features (e.g., falls at presentation and early in the disease course, poor response to levodopa, symmetry at onset, rapid progression [to Hoehn and Yahr stage 3 in 3 years], lack of tremor or dysautonomia) at least annually",Effective Clinical Care,Outcome,American Academy of Neurology,-,-,-,-,-,-,X,-,Parkinson's Disease,-,-,-,-,-,-,Measure Specification Manuals
,Parkinson’s Disease: Psychiatric Disorders or Disturbances Assessment,N/A,N/A,290,"All patients with a diagnosis of Parkinson’s disease who were assessed for psychiatric disorders or disturbances (e.g., psychosis, depression, anxiety disorder, apathy, or impulse control disorder) at least annually",Effective Clinical Care,Outcome,American Academy of Neurology,-,-,-,-,-,-,X,-,Parkinson's Disease,-,-,-,-,-,-,Measure Specification Manuals
,Parkinson’s Disease: Cognitive Impairment or Dysfunction Assessment,N/A,N/A,291,All patients with a diagnosis of Parkinson’s disease who were assessed for cognitive impairment or dysfunction at least annually,Effective Clinical Care,Outcome,American Academy of Neurology,-,-,-,-,-,-,X,-,Parkinson's Disease,-,-,-,-,-,-,Measure Specification Manuals
,Parkinson’s Disease: Querying about Sleep Disturbances,N/A,N/A,292,"All patients with a diagnosis of Parkinson’s disease (or caregivers, as appropriate) who were queried about sleep disturbances at least annually",Effective Clinical Care,Outcome,American Academy of Neurology,-,-,-,-,-,-,X,-,Parkinson's Disease,-,-,-,-,-,-,Measure Specification Manuals
,Parkinson’s Disease: Rehabilitative Therapy Options,N/A,N/A,293,"All patients with a diagnosis of Parkinson’s disease (or caregiver(s), as appropriate) who had rehabilitative therapy options (e.g., physical, occupational, or speech therapy) discussed at least annually",Communication and Care Coordination,Outcome,American Academy of Neurology,-,-,-,-,-,-,X,-,Parkinson's Disease,-,-,-,-,-,-,Measure Specification Manuals
,Parkinson’s Disease: Parkinson’s Disease Medical and Surgical Treatment Options Reviewed,N/A,N/A,294,"All patients with a diagnosis of Parkinson’s disease (or caregiver(s), as appropriate) who had the Parkinson’s disease treatment options (e.g., non-pharmacological treatment, pharmacological treatment, or surgical treatment) reviewed at least once annually",Communication and Care Coordination,Outcome,American Academy of Neurology,-,-,-,-,-,-,X,-,Parkinson's Disease,-,-,-,-,-,-,Measure Specification Manuals
,Cataracts: Improvement in Patient’s Visual Function within 90 Days Following Cataract Surgery,N/A,1536,303,"Percentage of patients aged 18 years and older in sample who had cataract surgery and had improvement in visual function achieved within 90 days following the cataract surgery, based on completing a pre-operative and post-operative visual function survey",Person and Caregiver-Centered Experience and Outcomes,Outcome,American Academy of Ophthalmology,-,-,-,-,-,-,X,X,Cataracts,-,-,-,-,-,-,Measure Specification Manuals
,Cataracts: Patient Satisfaction within 90 Days Following Cataract Surgery,N/A,N/A,304,"Percentage of patients aged 18 years and older in sample who had cataract surgery and were satisfied with their care within 90 days following the cataract surgery, based on completion of the Consumer Assessment of Healthcare Providers and Systems Surgical Care Survey",Person and Caregiver-Centered Experience and Outcomes,Outcome,American Academy of Ophthalmology,-,-,-,-,-,-,X,X,Cataracts,-,-,-,-,-,-,Measure Specification Manuals
,Initiation and Engagement of Alcohol and Other Drug Dependence Treatment,137v4,0004,305,"Percentage of patients 13 years of age and older with a new episode of alcohol and other drug (AOD) dependence who received the following. Two rates are reported.
a. Percentage of patients who initiated treatment within 14 days of the diagnosis.
b. Percentage of patients who initiated treatment and who had two or more additional services with an AOD diagnosis within 30 days of the initiation visit.
",Effective Clinical Care,Process,National Committee for Quality Assurance,-,-,-,-,X,-,-,-,-,-,-,-,-,X,-,Measure Specification Manuals
,Cervical Cancer Screening,124v4,0032,309,"Percentage of women 21-64 years of age, who received one or more Pap tests to screen for cervical cancer",Effective Clinical Care,Process,National Committee for Quality Assurance,-,-,-,-,X,-,-,-,-,-,-,-,-,X,-,Measure Specification Manuals
,Chlamydia Screening for Women,153v4,0033,310, Percentage of women 16-24 years of age who were identified as sexually active and who had at least one test for chlamydia during the measurement period,Community/Population Health,Process,National Committee for Quality Assurance,-,-,-,-,X,-,-,-,-,-,-,-,-,X,-,Measure Specification Manuals
,Use of Appropriate Medications for Asthma,126v4,0036,311,Percentage of patients 5-64 years of age who were identified as having persistent asthma and were appropriately prescribed medication during the measurement period,Effective Clinical Care,Process,National Committee for Quality Assurance,-,-,-,-,X,-,-,-,-,-,-,-,-,X,-,Measure Specification Manuals
,Use of Imaging Studies for Low Back Pain,166v5,0052,312,"Percentage of patients 18-50 years of age with a diagnosis of low back pain who did not have an imaging study (plain X-ray, MRI, CT scan) within 28 days of the diagnosis.",Efficiency and Cost Reduction,Process,National Committee for Quality Assurance,-,-,-,-,X,-,-,-,-,-,-,-,-,X,-,Measure Specification Manuals
,Preventive Care and Screening: Cholesterol – Fasting Low Density Lipoprotein (LDL-C) Test Performed AND Risk-Stratified Fasting LDL-C,61v5 & 64v5,N/A,316,"Percentage of patients aged 20 through 79 years whose risk factors* have been assessed and a fasting LDL test has been performed AND percentage of patients aged 20 through 79 years who had a fasting LDL-C test performed and whose risk-stratified fasting LDL-C is at or below the recommended LDL-C goal.
*There are three criteria for this measure based on the patient’s risk category.
1. Highest Level of Risk: Coronary Heart Disease (CHD) or CHD Risk Equivalent OR 10-Year Framingham Risk >20%
2. Moderate Level of Risk: Multiple (2+) Risk Factors OR 10-Year Framingham Risk 10-20%
3. Lowest Level of Risk: 0 or 1 Risk Factor OR 10-Year Framingham Risk <10%
",Effective Clinical Care, Intermediate Outcome,Centers for Medicare & Medicaid Services,Quality Insights of Pennsylvania,-,-,-,X,-,-,-,-,-,-,-,-,X,X,Measure Specification Manuals
,Preventive Care and Screening: Screening for High Blood Pressure and Follow-Up Documented,22v4,N/A,317,Percentage of patients aged 18 years and older seen during the reporting period who were screened for high blood pressure AND a recommended follow-up plan is documented based on the current blood pressure (BP) reading as indicated.,Community/Population Health,Process,Centers for Medicare & Medicaid Services,Mathematica,Quality Insights of Pennsylvania,X,-,X,X,X,X,"Acute Otitis Externa (AOE)
Cardiovascular Prevention
Diabetic Retinopathy",X,X,-,-,X,X,Measure Specification Manuals
,Falls: Screening for Fall Risk,139v4,0101,318,Percentage of patients 65 years of age and older who were screened for future fall risk at least once during the measurement period.,Patient Safety,Process,National Committee for Quality Assurance,-,-,-,-,X,X,-,-,-,X,X,-,-,X,-,Measure Specification Manuals
,Appropriate Follow-Up Interval for Normal Colonoscopy in Average Risk Patients,N/A,0658,320,Percentage of patients aged 50 to 75 years of age receiving a screening colonoscopy without biopsy or polypectomy who had a recommended follow-up interval of at least 10 years for repeat colonoscopy documented in their colonoscopy report,Communication and Care Coordination,Process,American Medical Association-Physician Consortium for Performance Improvement,American Gastroenterological Association,"American Society for Gastrointestinal Endoscopy/ American College of Gastroenterology
",X,-,-,-,-,X,-,-,-,-,-,-,-,Measure Specification Manuals
,CAHPS for PQRS Clinician/Group Survey,N/A,0005 & 0006,321,"• Getting timely care, appointments, and information;
• How well providers Communicate;
• Patient’s Rating of Provider;
• Access to Specialists;
• Health Promotion & Education;
• Shared Decision Making;
• Health Status/Functional Status;
• Courteous and Helpful Office Staff;
• Care Coordination;
• Between Visit Communication;
• Helping Your to Take Medication as Directed; and
• Stewardship of Patient Resources",Person and Caregiver-Centered Experience and Outcomes,Patient Engagement/Experience,Agency for Healthcare Research & Quality,-,-,-,X,-,-,-,-,-,X,X,-,-,-,-,Measure Specification Manuals
,Cardiac Stress Imaging Not Meeting Appropriate Use Criteria: Preoperative Evaluation in Low-Risk Surgery Patients,N/A,N/A,322,"Percentage of stress single-photon emission computed tomography (SPECT) myocardial perfusion imaging (MPI), stress echocardiogram (ECHO), cardiac computed tomography angiography (CCTA), or cardiac magnetic resonance (CMR) performed in low risk surgery patients 18 years or older for preoperative evaluation during the 12-month reporting period",Efficiency and Cost Reduction,Efficiency,American College of Cardiology,-,-,-,-,-,-,-,X,-,-,-,-,-,-,-,Measure Specification Manuals
,Cardiac Stress Imaging Not Meeting Appropriate Use Criteria: Routine Testing After Percutaneous Coronary Intervention (PCI),N/A,N/A,323,"Percentage of all stress  single-photon emission computed tomography (SPECT) myocardial perfusion imaging (MPI), stress echocardiogram (ECHO), cardiac computed tomography angiography (CCTA), and cardiovascular magnetic resonance (CMR) performed in patients aged 18 years and older routinely after percutaneous coronary intervention (PCI), with reference to timing of test after PCI and symptom status",Efficiency and Cost Reduction,Efficiency,American College of Cardiology,-,-,-,-,-,-,-,X,-,-,-,-,-,-,-,Measure Specification Manuals
,"Cardiac Stress Imaging Not Meeting Appropriate Use Criteria: Testing in Asymptomatic, Low-Risk Patients",N/A,N/A,324,"Percentage of all stress single-photon emission computed tomography (SPECT) myocardial perfusion imaging (MPI), stress echocardiogram (ECHO), cardiac computed tomography angiography (CCTA), and cardiovascular magnetic resonance (CMR) performed in asymptomatic, low coronary heart disease (CHD) risk patients 18 years and older for initial detection and risk assessment",Efficiency and Cost Reduction,Efficiency,American College of Cardiology,-,-,-,-,-,-,-,X,-,-,-,-,-,-,-,Measure Specification Manuals
,Adult Major Depressive Disorder (MDD): Coordination of Care of Patients with Specific Comorbid Conditions,N/A,N/A,325,"Percentage of medical records of patients aged 18 years and older with a diagnosis of major depressive disorder (MDD) and a specific diagnosed comorbid condition (diabetes, coronary artery disease, ischemic stroke, intracranial hemorrhage, chronic kidney disease [stages 4 or 5], End Stage Renal Disease [ESRD] or congestive heart failure) being treated by another clinician with communication to the clinician treating the comorbid condition",Communication and Care Coordination,Process,American Psychiatric Association,American Medical Association-Physician Consortium for Performance Improvement,-,-,-,-,-,-,X,-,-,-,-,-,-,-,Measure Specification Manuals
,Atrial Fibrillation and Atrial Flutter: Chronic Anticoagulation Therapy,N/A,1525,326,"Percentage of patients aged 18 years and older with a diagnosis of nonvalvular atrial fibrillation (AF) or atrial flutter whose assessment of the specified thromboembolic risk factors indicate one or more high-risk factors or more than one moderate risk factor, as determined by CHADS2 risk stratification, who are prescribed warfarin OR another oral anticoagulant drug that is FDA approved for the prevention of thromboembolism",Effective Clinical Care,Process,American College of Cardiology,American Heart Association,American Medical Association-Physician Consortium for Performance Improvement,X,-,-,-,-,X,-,-,-,-,-,-,-,Measure Specification Manuals
,Pediatric Kidney Disease: Adequacy of Volume Management: ,N/A,N/A,327,Percentage of calendar months within a 12-month period during which patients aged 17 years and younger with a diagnosis of End Stage Renal Disease (ESRD) undergoing maintenance hemodialysis in an outpatient dialysis facility have an assessment of the adequacy of volume management from a nephrologist ,Effective Clinical Care,Outcome,Renal Physicians Association,-,-,-,-,-,-,-,X,-,-,-,-,-,-,-,Measure Specification Manuals
,Pediatric Kidney Disease: ESRD Patients Receiving Dialysis: Hemoglobin Level < 10 g/Dl,N/A,1667,328,Percentage of calendar months within a 12-month period during which patients aged 17 years and younger with a diagnosis of End Stage Renal Disease (ESRD) receiving hemodialysis or peritoneal dialysis have a hemoglobin level < 10 g/dL,Effective Clinical Care, Intermediate Outcome,Renal Physicians Association,-,-,-,-,-,-,-,X,-,-,-,-,-,-,-,Measure Specification Manuals
,Adult Kidney Disease: Catheter Use at Initiation of Hemodialysis,N/A,N/A,329,"Percentage of patients aged 18 years and older with a diagnosis of End Stage Renal Disease (ESRD) who initiate maintenance hemodialysis during the measurement period, whose mode of vascular access is a catheter at the time maintenance hemodialysis is initiated",Effective Clinical Care,Outcome,Renal Physicians Association,-,-,-,-,-,-,-,X,-,-,-,-,-,-,-,Measure Specification Manuals
,Adult Kidney Disease: Catheter Use for Greater Than or Equal to 90 Days,N/A,N/A,330,Percentage of patients aged 18 years and older with a diagnosis of End Stage Renal Disease (ESRD) receiving maintenance hemodialysis for greater than or equal to 90 days whose mode of vascular access is a catheter,Patient Safety,Outcome,Renal Physicians Association,-,-,-,-,-,-,-,X,-,-,-,-,-,-,-,Measure Specification Manuals
,Adult Sinusitis: Antibiotic Prescribed for Acute Sinusitis (Overuse) ,N/A,N/A,331,"Percentage of patients, aged 18 years and older, with a diagnosis of acute sinusitis who were prescribed an antibiotic within 10 days after onset of symptoms",Efficiency and Cost Reduction,Process,American Academy of Otolaryngology-Head and Neck Surgery,-,-,-,-,-,-,X,X,Sinusitis ,-,-,-,-,-,-,Measure Specification Manuals
,Adult Sinusitis: Appropriate Choice of Antibiotic: Amoxicillin With or Without Clavulanate Prescribed for Patients with Acute Bacterial Sinusitis (Appropriate Use) ,N/A,N/A,332,"Percentage of patients aged 18 years and older with a diagnosis of acute bacterial sinusitis that were prescribed amoxicillin, with or without clavulante, as a first line antibiotic at the time of diagnosis",Efficiency and Cost Reduction,Process,American Academy of Otolaryngology-Head and Neck Surgery,-,-,-,-,-,-,X,X,Sinusitis ,-,-,-,-,-,-,Measure Specification Manuals
,Adult Sinusitis: Computerized Tomography (CT) for Acute Sinusitis (Overuse),N/A,N/A,333,Percentage of patients aged 18 years and older with a diagnosis of acute sinusitis who had a computerized tomography (CT) scan of the paranasal sinuses ordered at the time of diagnosis or received within 28 days after date of diagnosis,Efficiency and Cost Reduction,Efficiency,American Academy of Otolaryngology-Head and Neck Surgery,-,-,-,-,-,-,X,X,Sinusitis ,-,-,-,-,-,-,Measure Specification Manuals
,Adult Sinusitis: More than One Computerized Tomography (CT) Scan Within 90 Days for Chronic Sinusitis (Overuse),N/A,N/A,334,Percentage of patients aged 18 years and older with a diagnosis of chronic sinusitis who had more than one CT scan of the paranasal sinuses ordered or received within 90 days after the date of diagnosis,Efficiency and Cost Reduction,Efficiency,American Academy of Otolaryngology-Head and Neck Surgery,-,-,-,-,-,-,-,X,-,-,-,-,-,-,-,Measure Specification Manuals
,Maternity Care: Elective Delivery or Early Induction Without Medical Indication at ≥ 37 and < 39 Weeks,N/A,N/A,335,"Percentage of patients, regardless of age, who gave birth during a 12-month period who delivered a live singleton at ≥ 37 and < 39 weeks of gestation completed who had elective deliveries or early inductions without medical indication",Patient Safety,Outcome,American Medical Association-Physician Consortium for Performance Improvement,-,-,-,-,-,-,-,X,-,-,-,-,-,-,-,Measure Specification Manuals
,Maternity Care: Post-Partum Follow-Up and Care Coordination,N/A,N/A,336,"Percentage of patients, regardless of age, who gave birth during a 12-month period who were seen for post-partum care within 8 weeks of giving birth who received a breast feeding evaluation and education, post-partum depression screening, post-partum glucose screening for gestational diabetes patients, and family and contraceptive planning",Communication and Care Coordination,Process,American Medical Association-Physician Consortium for Performance Improvement,-,-,-,-,-,-,-,X,-,-,-,-,-,-,-,Measure Specification Manuals
,"Tuberculosis Prevention for Psoriasis,Psoriatic Arthritis and Rheumatoid Arthritis Patients on a Biological Immune Response Modifier",N/A,N/A,337,Percentage of patients whose providers are ensuring active tuberculosis prevention either through yearly negative standard tuberculosis screening tests or are reviewing the patient’s history to determine if they have had appropriate management for a recent or prior positive test,Effective Clinical Care,Process,American Academy of Dermatology,-,-,-,-,-,-,X,X,Rheumatoid Arthritis,-,-,-,-,-,-,Measure Specification Manuals
,HIV Viral Load Suppression,N/A,2082,338,"The percentage of patients, regardless of age, with a diagnosis of HIV with a HIV viral load less than 200 copies/mL at last HIV viral load test during the measurement year",Effective Clinical Care,Outcome,Health Resources and Services Administration,-,-,-,-,-,-,X,-,HIV/AIDS,-,-,-,-,-,-,Measure Specification Manuals
,Prescription of HIV Antiretroviral Therapy,N/A,2083,339,"Percentage of patients, regardless of age, with a diagnosis of HIV prescribed antiretroviral therapy for the treatment of HIV infection during the measurement year",Effective Clinical Care,Process,Health Resources and Services Administration,-,-,-,-,-,-,X,-,HIV/AIDS,-,-,-,-,-,-,Measure Specification Manuals
,HIV Medical Visit Frequency,N/A,2079,340,"Percentage of patients, regardless of age with a diagnosis of HIV who had at least one medical visit in each 6 month period of the 24 month measurement period, with a minimum of 60 days between medical visits",Efficiency and Cost Reduction,Process,Health Resources and Services Administration,-,-,-,-,-,-,X,-,HIV/AIDS,-,-,-,-,-,-,Measure Specification Manuals
,Pain Brought Under Control Within 48 Hours,N/A,N/A,342,Patients aged 18 and older who report being uncomfortable because of pain at the initial assessment (after admission to palliative care services) who report pain was brought to a comfortable level within 48 hours,Person and Caregiver-Centered Experience and Outcomes,Outcome,National Hospice and Palliative Care Organization,-,-,-,-,-,-,-,X,-,-,-,-,-,-,-,Measure Specification Manuals
,Screening Colonoscopy Adenoma Detection Rate Measure,N/A,N/A,343,The percentage of patients age 50 years or older with at least one conventional adenoma or colorectal cancer detected during screening colonoscopy,Effective Clinical Care,Outcome,American College of Gastroenterology,American Gastroenterological Association,American Society for Gastrointestinal Endoscopy,-,-,-,-,-,X,-,-,-,-,-,-,-,Measure Specification Manuals
,"Rate of Carotid Artery Stenting (CAS) for Asymptomatic Patients, Without Major Complications (Discharged to Home by Post-Operative Day #2)",N/A,N/A,344,Percent of asymptomatic patients undergoing CAS who are discharged to home no later than post-operative day #2,Effective Clinical Care,Outcome,Society for Vascular Surgeons,-,-,-,-,-,-,-,X,-,-,-,-,-,-,-,Measure Specification Manuals
,Rate of Postoperative Stroke or Death in Asymptomatic Patients Undergoing Carotid Artery Stenting (CAS),N/A,1543,345,Percent of asymptomatic patients undergoing CAS who experience stroke or death following surgery while in the hospital,Effective Clinical Care,Outcome,Society for Vascular Surgeons,-,-,-,-,-,-,-,X,-,-,-,-,-,-,-,Measure Specification Manuals
,Rate of Postoperative Stroke or Death in Asymptomatic Patients Undergoing Carotid Endarterectomy (CEA),N/A,1540,346,Percent of asymptomatic patients undergoing CEA who experience stroke or death following surgery while in the hospital,Effective Clinical Care,Outcome,Society for Vascular Surgeons,-,-,-,-,-,-,-,X,-,-,-,-,-,-,-,Measure Specification Manuals
,Rate of Endovascular Aneurysm Repair (EVAR) of Small or Moderate Non-Ruptured Abdominal Aortic Aneurysms (AAA) Who Die While in Hospital,N/A,1534,347,Percent of patients undergoing endovascular repair of small or moderate abdominal aortic aneurysms (AAA) who die while in the hospital,Patient Safety,Outcome,Society for Vascular Surgeons,-,-,-,-,-,-,-,X,-,-,-,-,-,-,-,Measure Specification Manuals
,HRS-3: Implantable Cardioverter-Defibrillator (ICD) Complications Rate,N/A,N/A,348,Patients with physician-specific risk-standardized rates of procedural complications following the first time implantation of an ICD,Patient Safety,Outcome,The Heart Rhythm Society,-,-,-,-,-,-,-,X,-,-,-,-,-,-,-,Measure Specification Manuals
,Total Knee Replacement: Shared Decision-Making: Trial of Conservative (Non-surgical) Therapy,N/A,N/A,350,"Percentage of patients regardless of age or gender undergoing a total knee replacement with documented shared decision-making with discussion of conservative (non-surgical) therapy (e.g.  Nonsteroidal anti-inflammatory drugs (NSAIDs), analgesics, weight loss, exercise, injections) prior to the procedure",Communication and Care Coordination,Outcome,American Association of Hip and Knee Surgeons,-,-,-,-,-,-,X,-,Total Knee Replacement,-,-,-,-,-,-,Measure Specification Manuals
,Total Knee Replacement: Venous Thromboembolic and Cardiovascular Risk Evaluation,N/A,N/A,351,"Percentage of patients regardless of age or gender undergoing a total knee replacement who are evaluated for the presence or absence of venous thromboembolic and cardiovascular risk factors within 30 days prior to the procedure (e.g. history of Deep Vein Thrombosis (DVT), Pulmonary Embolism (PE), Myocardial Infarction (MI), Arrhythmia and Stroke)",Patient Safety,Outcome,American Association of Hip and Knee Surgeons,-,-,-,-,-,-,X,-,Total Knee Replacement,-,-,-,-,-,-,Measure Specification Manuals
,Total Knee Replacement: Preoperative Antibiotic Infusion with Proximal Tourniquet,N/A,N/A,352,Percentage of patients regardless of age or gender undergoing a total knee replacement who had the prophylactic antibiotic completely infused prior to the inflation of the proximal tourniquet,Patient Safety,Outcome,American Association of Hip and Knee Surgeons,-,-,-,-,-,-,X,-,Total Knee Replacement,-,-,-,-,-,-,Measure Specification Manuals
,Total Knee Replacement: Identification of Implanted Prosthesis in Operative Report,N/A,N/A,353,"Percentage of patients regardless of age or gender undergoing a total knee replacement whose operative report identifies the prosthetic implant specifications including the prosthetic implant manufacturer, the brand name of the prosthetic implant and the size of each prosthetic implant",Patient Safety,Outcome,American Association of Hip and Knee Surgeons,-,-,-,-,-,-,X,-,Total Knee Replacement,-,-,-,-,-,-,Measure Specification Manuals
,Anastomotic Leak Intervention,N/A,N/A,354,Percentage of patients aged 18 years and older who required an anastomotic leak intervention following gastric bypass or colectomy surgery,Patient Safety,Outcome,American College of Surgeons,-,-,-,-,-,-,X,-,General Surgery,-,-,-,-,-,-,Measure Specification Manuals
,Unplanned Reoperation within the 30 Day Postoperative Period,N/A,N/A,355,Percentage of patients aged 18 years and older who had any unplanned reoperation within the 30 day postoperative period,Patient Safety,Outcome,American College of Surgeons,-,-,-,-,-,-,X,-,General Surgery,-,-,-,-,-,-,Measure Specification Manuals
,Unplanned Hospital Readmission within 30 Days of Principal Procedure,N/A,N/A,356,Percentage of patients aged 18 years and older who had an unplanned hospital readmission within 30 days of principal procedure ,Effective Clinical Care,Outcome,American College of Surgeons,-,-,-,-,-,-,X,-,General Surgery,-,-,-,-,-,-,Measure Specification Manuals
,Surgical Site Infection (SSI),N/A,N/A,357,Percentage of patients aged 18 years and older who had a surgical site infection (SSI),Effective Clinical Care,Outcome,American College of Surgeons,-,-,-,-,-,-,X,-,General Surgery,-,-,-,-,-,-,Measure Specification Manuals
,Patient-Centered Surgical Risk Assessment and Communication,N/A,N/A,358,"Percentage of patients who underwent a non-emergency surgery who had their personalized risks of postoperative complications assessed by their surgical team prior to surgery using a clinical data-based, patient-specific risk calculator and who received personal discussion of those risks with the surgeon",Person and Caregiver-Centered Experience and Outcomes,Process,American College of Surgeons,-,-,-,-,-,-,X,X,General Surgery,-,-,-,-,-,-,Measure Specification Manuals
,Optimizing Patient Exposure to Ionizing Radiation: Utilization of a Standardized Nomenclature for Computed Tomography (CT) Imaging Description,N/A,N/A,359,"Percentage of computed tomography (CT) imaging reports for all patients, regardless of age, with the imaging study named according to a standardized nomenclature and the standardized nomenclature is used in institution’s computer systems",Communication and Care Coordination,Process,American College of Radiology,-,-,-,-,-,-,X,-,Optimizing Patient Exposure to Ionizing Radiation,-,-,-,-,-,-,Measure Specification Manuals
,Optimizing Patient Exposure to Ionizing Radiation: Count of Potential High Dose Radiation Imaging Studies: Computed Tomography (CT) and Cardiac Nuclear Medicine Studies,N/A,N/A,360,"Percentage of computed tomography (CT) and cardiac nuclear medicine (myocardial perfusion studies) imaging reports for all patients, regardless of age, that document a count of known previous CT (any type of CT) and cardiac nuclear medicine (myocardial perfusion) studies that the patient has received in the 12-month period prior to the current study",Patient Safety,Process,American College of Radiology,-,-,-,-,-,-,X,-,Optimizing Patient Exposure to Ionizing Radiation,-,-,-,-,-,-,Measure Specification Manuals
,Optimizing Patient Exposure to Ionizing Radiation: Reporting to a Radiation Dose Index Registry,N/A,N/A,361,"Percentage of total computed tomography (CT) studies performed for all patients, regardless of age, that are reported to a radiation dose index registry AND that include at a minimum selected data elements",Patient Safety,Structure,American College of Radiology,-,-,-,-,-,-,X,-,Optimizing Patient Exposure to Ionizing Radiation,-,-,-,-,-,-,Measure Specification Manuals
,Optimizing Patient Exposure to Ionizing Radiation: Computed Tomography (CT) Images Available for Patient Follow-up and Comparison Purposes,N/A,N/A,362,"Percentage of final reports for computed tomography (CT) studies performed for all patients, regardless of age, which document that Digital Imaging and Communications in Medicine (DICOM) format image data are available to non-affiliated external healthcare facilities or entities on a secure, media free, reciprocally searchable basis with patient authorization for at least a 12-month period after the study",Communication and Care Coordination,Structure,American College of Radiology,-,-,-,-,-,-,X,-,Optimizing Patient Exposure to Ionizing Radiation,-,-,-,-,-,-,Measure Specification Manuals
,"Optimizing Patient Exposure to Ionizing Radiation: Search for Prior Computed Tomography (CT) Studies Through a Secure, Authorized, Media-Free, Shared Archive",N/A,N/A,363,"Percentage of final reports of computed tomography (CT) studies performed for all patients, regardless of age, which document that a search for Digital Imaging and Communications in Medicine (DICOM) format images was conducted for prior patient CT imaging studies completed at non-affiliated external healthcare facilities or entities within the past 12-months and are available through a secure, authorized, media free, shared archive prior to an imaging study being performed",Communication and Care Coordination,Structure,American College of Radiology,-,-,-,-,-,-,X,-,Optimizing Patient Exposure to Ionizing Radiation,-,-,-,-,-,-,Measure Specification Manuals
,Optimizing Patient Exposure to Ionizing Radiation: Appropriateness: Follow-up CT Imaging for Incidentally Detected Pulmonary Nodules According to Recommended Guidelines,N/A,N/A,364,"Percentage of final reports for computed tomography (CT) imaging studies of the thorax for patients aged 18 years and older with documented follow-up recommendations for incidentally detected pulmonary nodules (e.g., follow-up CT imaging studies needed or that no follow-up is needed) based at a minimum on nodule size AND patient risk factors",Communication and Care Coordination,Process,American College of Radiology,-,-,-,-,-,-,X,-,Optimizing Patient Exposure to Ionizing Radiation,-,-,-,-,-,-,Measure Specification Manuals
,Hemoglobin A1c Test for Pediatric Patients,148v4,N/A,365,Percentage of patients 5-17 years of age with diabetes with a HbA1c test during the measurement period,Effective Clinical Care,Process,National Committee for Quality Assurance,-,-,-,-,X,-,-,-,-,-,-,-,-,X,-,Measure Specification Manuals
,ADHD: Follow-Up Care for Children Prescribed Attention-Deficit/Hyperactivity Disorder (ADHD) Medication,136v5,0108,366,"Percentage of children 6-12 years of age and newly dispensed a medication for attention-deficit/hyperactivity disorder (ADHD) who had appropriate follow-up care.  Two rates are reported.  
a. Percentage of children who had one follow-up visit with a practitioner with prescribing authority during the 30-Day Initiation Phase.
b. Percentage of children who remained on ADHD medication for at least 210 days and who, in addition to the visit in the Initiation Phase, had at least two additional follow-up visits with a practitioner within 270 days (9 months) after the Initiation Phase ended
",Effective Clinical Care,Process,National Committee for Quality Assurance,-,-,-,-,X,-,-,-,-,-,-,-,-,X,-,Measure Specification Manuals
,Bipolar Disorder and Major Depression: Appraisal for Alcohol or Chemical Substance Use,169v4,N/A,367,Percentage of patients with depression or bipolar disorder with evidence of an initial assessment that includes an appraisal for alcohol or chemical substance use.,Effective Clinical Care,Process,Center for Quality Assessment and Improvement in Mental Health,-,-,-,-,X,-,-,-,-,-,-,-,-,X,-,Measure Specification Manuals
,HIV/AIDS: Medical Visit,62v4,N/A,368,"Percentage of patients, regardless of age, with a diagnosis of HIV/AIDS with at least two medical visits during the measurement year with a minimum of 90 days between each visit",Effective Clinical Care,Process,National Committee for Quality Assurance,-,-,-,-,X,-,-,-,-,-,-,-,-,X,-,Measure Specification Manuals
,Pregnant Women that had HBsAg Testing,158v4,N/A,369,This measure identifies pregnant women who had a HBsAg (hepatitis B) test during their pregnancy.,Effective Clinical Care,Process,OptumInsight,-,-,-,-,X,-,-,-,-,-,-,-,-,X,-,Measure Specification Manuals
,Depression Remission at Twelve Months,159v4,0710,370,Adult patients age 18 and older with major depression or dysthymia and an initial PHQ-9 score > 9 who demonstrate remission at twelve months defined as PHQ-9 score less than 5. This measure applies to both patients with newly diagnosed and existing depression whose current PHQ-9 score indicates a need for treatment,Effective Clinical Care,Intermediate Outcome,Minnesota Community Measurement,-,-,-,-,X,X,-,X,-,-,-,-,-,X,-,Measure Specification Manuals
,Depression Utilization of the PHQ-9 Tool,160v4,0712,371,Adult patients age 18 and older with the diagnosis of major depression or dysthymia who have a PHQ-9 tool administered at least once during a 4 month period in which there was a qualifying visit.,Effective Clinical Care,Process,Minnesota Community Measurement,-,-,-,-,X,-,-,-,-,-,-,-,-,X,-,Measure Specification Manuals
,Maternal Depression Screening,82v3,N/A,372,"The percentage of children who turned 6 months of age during the measurement year, who had a face-to-face visit between the clinician and the child during child’s first 6 months, and who had a maternal depression screening for the mother at least once between 0 and 6 months of life.",Community/Population Health,Process,National Committee for Quality Assurance,-,-,-,-,X,-,-,-,-,-,-,-,-,X,-,Measure Specification Manuals
,Hypertension: Improvement in Blood Pressure,65v5,N/A,373,Percentage of patients aged 18-85 years of age with a diagnosis of hypertension whose blood pressure improved during the measurement period.,Effective Clinical Care,Intermediate Outcome,Centers for Medicare & Medicaid Services,National Committee for Quality Assurance,-,-,-,X,-,-,-,-,-,-,-,-,X,-,Measure Specification Manuals
,Closing the Referral Loop: Receipt of Specialist Report,50v4,N/A,374,"Percentage of patients with referrals, regardless of age, for which the referring provider receives a report from the provider to whom the patient was referred.",Communication and Care Coordination,Process,Centers for Medicare & Medicaid Services,Mathematica,-,-,-,X,-,-,-,-,X,-,-,-,X,-,Measure Specification Manuals
,Functional Status Assessment for Knee Replacement,66v4,N/A,375,Percentage of patients aged 18 years and older with primary total knee arthroplasty (TKA) who completed  baseline and follow-up (patient-reported) functional status assessments.,Person and Caregiver-Centered Experience and Outcomes,Process,Centers for Medicare & Medicaid Services,National Committee for Quality Assurance,-,-,-,X,-,-,-,-,-,-,-,-,X,-,Measure Specification Manuals
,Functional Status Assessment for Hip Replacement,56v4,N/A,376,Percentage of patients aged 18 years and older with primary total hip arthroplasty (THA) who completed baseline and follow-up (patient-reported) functional status assessments,Person and Caregiver-Centered Experience and Outcomes,Process,Centers for Medicare & Medicaid Services,National Committee for Quality Assurance,-,-,-,X,-,-,-,-,-,-,-,-,X,-,Measure Specification Manuals
,Functional Status Assessment for Complex Chronic Conditions,90v4,N/A,377,Percentage of patients aged 65 years and older with heart failure who completed initial and follow-up patient-reported functional status assessments,Person and Caregiver-Centered Experience and Outcomes,Process,Centers for Medicare & Medicaid Services,Mathematica,-,-,-,X,-,-,-,-,-,-,-,-,X,-,Measure Specification Manuals
,Children Who Have Dental Decay or Cavities,75v4,N/A,378,"Percentage of children, age 0-20 years, who have had tooth decay or cavities during the measurement period",Community/Population Health,Outcome,Centers for Medicare & Medicaid Services,Mathematica,-,-,-,X,-,-,-,-,-,-,-,-,X,-,Measure Specification Manuals
,"Primary Caries Prevention Intervention as Offered by Primary Care Providers, including Dentists",74v5,N/A,379,"Percentage of children, age 0-20 years, who received a fluoride varnish application during the measurement period.",Effective Clinical Care,Process,Centers for Medicare & Medicaid Services,National Committee for Quality Assurance,-,-,-,X,-,-,-,-,-,-,-,-,X,-,Measure Specification Manuals
,ADE Prevention and Monitoring:  Warfarin Time in Therapeutic Range,179v4,N/A,380,"Average percentage of time in which patients aged 18 and older with atrial fibrillation who are on chronic warfarin therapy have International Normalized Ratio (INR) test results within the therapeutic range (i.e., TTR) during the measurement period",Patient Safety,Intermediate Outcome,Centers for Medicare & Medicaid Services,National Committee for Quality Assurance,-,-,-,X,-,-,-,-,-,-,-,-,X,-,Measure Specification Manuals
,HIV/AIDS: RNA Control for Patients with HIV,77v4,N/A,381,"Percentage of patients aged 13 years and older with a diagnosis of HIV/AIDS, with at least two visits during the measurement year, with at least 90 days between each visit, whose most recent HIV RNA level is <200 copies/mL.",Effective Clinical Care,Outcome,Centers for Medicare & Medicaid Services,National Committee for Quality Assurance,-,-,-,X,-,-,-,-,-,-,-,-,X,-,Measure Specification Manuals
,Child and Adolescent Major Depressive Disorder (MDD): Suicide Risk Assessment,177v4,1365,382,Percentage of patient visits for those patients aged 6 through 17 years with a diagnosis of major depressive disorder with an assessment for suicide risk,Patient Safety,Process,American Medical Association-Physician Consortium for Performance Improvement,-,-,-,-,X,-,-,-,-,-,-,-,-,X,-,Measure Specification Manuals
,Adherence to Antipsychotic Medications for Individuals with Schizophrenia,N/A,1879,383,Percentage of individuals at least 18 years of age as of the beginning of the measurement period with schizophrenia or schizoaffective disorder who had at least two prescriptions filled for any antipsychotic medication and who had a Proportion of Days Covered (PDC) of at least 0.8 for antipsychotic medications during the measurement period (12 consecutive months),Patient Safety,Intermediate Outcome,Health Services Advisory Group ,Centers for Medicare & Medicaid Services,-,-,-,-,-,-,X,-,-,-,-,-,-,-,Measure Specification Manuals
,Adult Primary Rhegmatogenous Retinal Detachment Surgery: No Return to the Operating Room Within 90 Days of Surgery,N/A,N/A,384,Patients aged 18 years and older who had surgery for primary rhegmatogenous retinal detachment who did not require a return to the operating room within 90 days of surgery.,Effective Clinical Care,Outcome,American Academy of Ophthalmology,-,-,-,-,-,-,-,X,-,-,-,-,-,-,-,Measure Specification Manuals
,Adult Primary Rhegmatogenous Retinal Detachment Surgery: Visual Acuity Improvement Within 90 Days of Surgery,N/A,N/A,385,"Patients aged 18 years and older who had surgery for primary rhegmatogenous retinal detachment and achieved an improvement in their visual acuity, from their preoperative level, within 90 days of surgery in the operative eye",Effective Clinical Care,Outcome,American Academy of Ophthalmology,The Australian Council on Healthcare Standards,-,-,-,-,-,-,X,-,-,-,-,-,-,-,Measure Specification Manuals
,Amyotrophic Lateral Sclerosis (ALS) Patient Care Preferences,N/A,N/A,386,"Percentage of patients diagnosed with Amyotrophic Lateral Sclerosis (ALS) who were offered assistance in planning for end of life issues (e.g. advance directives, invasive ventilation, hospice) at least once annually",Person and Caregiver-Centered Experience and Outcomes,Process,American Academy of Neurology,-,-,-,-,-,-,-,X,-,-,-,-,-,-,-,Measure Specification Manuals
,Annual Hepatitis C Virus (HCV) Screening for Patients who are Active Injection Drug Users,N/A,N/A,387,Percentage of patients regardless of age who are active injection drug users who received screening for HCV infection within the 12 month reporting period,Effective Clinical Care,Process,American Medical Association-Physician Consortium for Performance Improvement,-,-,-,-,-,-,-,X,-,-,-,-,-,-,-,Measure Specification Manuals
,Cataract Surgery with Intra-Operative Complications (Unplanned Rupture of Posterior Capsule Requiring Unplanned Vitrectomy,N/A,N/A,388,Percentage of patients aged 18 years and older who had cataract surgery performed and had an unplanned rupture of the posterior capsule requiring vitrectomy,Patient Safety,Outcome,American Academy of Ophthalmology,American College of Healthcare Sciences,-,-,-,-,-,X,X,Cataracts,-,-,-,-,-,-,Measure Specification Manuals
,Cataract Surgery: Difference Between Planned and Final Refraction,N/A,N/A,389,Percentage of patients aged 18 years and older who had cataract surgery performed and who achieved a final refraction within +/- 1.0 diopters of their planned (target) refraction.,Effective Clinical Care,Outcome,American Academy of Ophthalmology,American College of Healthcare Sciences,-,-,-,-,-,X,X,Cataracts,-,-,-,-,-,-,Measure Specification Manuals
,Hepatitis C: Discussion and Shared Decision Making Surrounding Treatment Options,N/A,N/A,390,"Percentage of patients aged 18 years and older with a diagnosis of hepatitis C with whom a physician or other qualified healthcare professional reviewed the range of treatment options appropriate to their genotype and demonstrated a shared decision making approach with the patient. To meet the measure, there must be documentation in the patient record of a discussion between the physician or other qualified healthcare professional and the patient that includes all of the following: treatment choices appropriate to genotype, risks and benefits, evidence of effectiveness, and patient preferences toward treatment
",Person and Caregiver-Centered Experience and Outcomes,Process,American Medical Association-Physician Consortium for Performance Improvement,American Gastroenterological Association,-,-,-,-,-,X,X,Hepatitis C,-,-,-,-,-,-,Measure Specification Manuals
,Follow-up After Hospitalization for Mental Illness (FUH),N/A,0576,391,"The percentage of discharges for patients 6 years of age and older who were hospitalized for treatment of selected mental illness diagnoses and who had an outpatient visit, an intensive outpatient encounter or partial hospitalization with a mental health practitioner. Two rates are reported: 
- The percentage of discharges for which the patient received follow-up within 30 days of discharge 
- The percentage of discharges for which the patient received follow-up within 7 days of discharge.
",Communication and Care Coordination,Process,National Committee for Quality Assurance,-,-,-,-,-,-,-,X,-,-,-,-,-,-,-,Measure Specification Manuals
,HRS-12: Cardiac Tamponade and/or Pericardiocentesis Following Atrial Fibrillation Ablation,N/A,2474,392,"Rate of cardiac tamponade and/or pericardiocentesis following atrial fibrillation ablation 
This measure is reported as four rates stratified by age and gender: 
• Reporting Age Criteria 1: Females less than 65 years of age 
• Reporting Age Criteria 2: Males less than 65 years of age 
• Reporting Age Criteria 3: Females 65 years of age and older 
• Reporting Age Criteria 4: Males 65 years of age and older",Patient Safety,Outcome,The Heart Rhythm Society,-,-,-,-,-,-,-,X,-,-,-,-,-,-,-,Measure Specification Manuals
,"HRS-9: Infection within 180 Days of Cardiac Implantable Electronic Device (CIED) Implantation, Replacement, or Revision
",N/A,N/A,393,"Infection rate following CIED device implantation, replacement, or revision
",Patient Safety,Outcome,The Heart Rhythm Society,-,-,-,-,-,-,-,X,-,-,-,-,-,-,-,Measure Specification Manuals
,Immunizations for Adolescents,N/A,1407,394,The percentage of adolescents 13 years of age who had the recommended immunizations by their 13th birthday.,Community/Population Health,Process,National Committee for Quality Assurance,-,-,-,-,-,-,-,X,-,-,-,-,-,-,-,Measure Specification Manuals
,Lung Cancer Reporting (Biopsy/Cytology Specimens),N/A,N/A,395,Pathology reports based on biopsy and/or cytology specimens with a diagnosis of primary nonsmall cell lung cancer classified into specific histologic type or classified as NSCLC-NOS with an explanation included in the pathology report.,Communication and Care Coordination,Process,College of American Pathologists,-,-,X,-,-,-,-,X,-,-,-,-,-,-,-,Measure Specification Manuals
,Lung Cancer Reporting (Resection Specimens),N/A,N/A,396,"Pathology reports based on resection specimens with a diagnosis of primary lung carcinoma that include the pT category, pN category and for non-small cell lung cancer, histologic type.",Communication and Care Coordination,Process,College of American Pathologists,-,-,X,-,-,-,-,X,-,-,-,-,-,-,-,Measure Specification Manuals
,Melanoma Reporting,N/A,N/A,397,"Pathology reports for primary malignant cutaneous melanoma that include the pT category and a statement on thickness and ulceration and for pT1, mitotic rate.",Communication and Care Coordination,Process,College of American Pathologists,-,-,X,-,-,-,-,X,-,-,-,-,-,-,-,Measure Specification Manuals
,Optimal Asthma Control ,N/A,N/A,398,Patients ages 5-50 (pediatrics ages 5-17) whose asthma is well-controlled as demonstrated by one of three age appropriate patient reported outcome tools.,Effective Clinical Care,Outcome,Minnesota Community Measurement,-,-,-,-,-,-,-,X,-,-,-,-,-,-,-,Measure Specification Manuals
,Post-Procedural Optimal Medical Therapy Composite (Percutaneous Coronary Intervention),N/A,2452,399,Percentage of patients aged 18 years and older for whom PCI is performed who are prescribed optimal medical therapy at discharge,Effective Clinical Care,Process,American College of Cardiology,American Heart Association,American Medical Association-Physician Consortium for Performance Improvement,-,-,-,-,-,X,-,-,-,-,-,-,-,Measure Specification Manuals
,One-Time Screening for Hepatitis C Virus (HCV) for Patients at Risk,N/A,N/A,400,"Percentage of patients aged 18 years and older with one or more of the following: a history of injection drug use, receipt of a blood transfusion prior to 1992, receiving maintenance hemodialysis OR birthdate in the years 1945-1965 who received a one-time screening for HCV infection",Effective Clinical Care,Process,American Medical Association-Physician Consortium for Performance Improvement,-,-,-,-,-,-,-,X,-,X,-,-,-,-,-,Measure Specification Manuals
,Hepatitis C: Screening for Hepatocellular Carcinoma (HCC) in Patients with Cirrhosis,N/A,N/A,401,"Percentage of patients aged 18 years and older with a diagnosis of chronic hepatitis C cirrhosis who underwent imaging with either ultrasound, contrast enhanced CT or MRI for hepatocellular carcinoma (HCC) at least once within the 12 month reporting period",Effective Clinical Care,Process,American Medical Association-Physician Consortium for Performance Improvement,American Gastroenterological Association,-,-,-,-,-,X,X,Hepatitis C,-,-,-,-,-,-,Measure Specification Manuals
,Tobacco Use and Help with Quitting Among Adolescents,N/A,N/A,402,The percentage of adolescents 12 to 20 years of age with a primary care visit during the measurement year for whom tobacco use status was documented and received help with quitting if identified as a tobacco user,Community/Population Health,Process,National Committee for Quality Assurance,National Collaborative for Innovation in Quality Measurement,-,-,-,-,-,X,X,Asthma,X,-,-,-,-,-,Measure Specification Manuals
,Adult Kidney Disease: Referral to Hospice,N/A,N/A,403,Percentage of patients aged 18 years and older with a diagnosis of end-stage renal disease (ESRD) who withdraw from hemodialysis peritoneal dialysis who are referred to hospice care.,Person and Caregiver-Centered Experience and Outcomes,Process,Renal Physicians Association,American Medical Association-Physician Consortium for Performance Improvement,-,-,-,-,-,-,X,-,-,,,,,,Measure Specification Manuals
,Anesthesiology Smoking Abstinence,N/A,N/A,404,The percentage of current smokers who abstain from cigarettes prior to anesthesia on the day of elective surgery or procedure.,Effective Clinical Care,Intermediate Outcome,American Society of Anesthesiologists,-,-,-,-,-,-,-,X,-,-,,,,,,Measure Specification Manuals
,Appropriate Follow-up Imaging for Incidental Abdominal  Lesions,N/A,N/A,405,"Percentage of final reports for abdominal imaging studies for asymptomatic patients aged 18 years and older with one or more of the following noted incidentally with follow‐up imaging recommended:
• Liver lesion ≤ 0.5 cm 
• Cystic kidney lesion < 1.0 cm 
• Adrenal lesion ≤ 1.0 cm

",Effective Clinical Care,Process,American College of Radiology,-,-,X,-,-,-,-,X,-,-,,,,,,Measure Specification Manuals
,Appropriate Follow-Up Imaging for Incidental Thyroid Nodules in Patients,N/A,N/A,406,Percentage of final reports for computed tomography (CT) or magnetic resonance imaging (MRI) studies of the chest or neck or ultrasound of the neck for patients aged 18 years and older with no known thyroid disease with a thyroid nodule < 1.0 cm noted incidentally with follow-up imaging recommended ,Effective Clinical Care,Process,American College of Radiology,-,-,X,-,-,-,-,X,-,-,,,,,,Measure Specification Manuals
,Appropriate Treatment of Meticillin-Sensitive Staphylococcus Aureus (MSSA) Bacteremia,N/A,N/A,407,"Percentage of patients with sepsis due to Meticillin-Sensitive Staphylococcus Aureus (MSSA) bacteremia who received beta-lactam antibiotic (e.g. nafcillin, oxacillin or cefazolin) as definitive therapy.",Effective Clinical Care,Process,Infectious Diseases Society of America,-,-,X,-,-,-,-,X,-,-,,,,,,Measure Specification Manuals
,Opioid Therapy Follow-up Evaluation,N/A,N/A,408,All patients 18 and older prescribed opiates for longer than six weeks duration who had a follow-up evaluation conducted at least every three months during Opioid Therapy documented in the medical record.,Effective Clinical Care,Process,American Academy of Neurology,-,-,-,-,-,-,-,X,-,-,,,,,,Measure Specification Manuals
,Clinical Outcome Post-Endovascular Stroke Treatment,N/A,N/A,409,Percentage of patients with a mRs score of 0 to 2 at 90 days following endovascular stroke intervention.,Effective Clinical Care,Outcome,Society of Interventional Radiology ,-,-,-,-,-,-,-,X,-,-,,,,,,Measure Specification Manuals
,Psoriasis: Clinical Response to Oral Systemic or Biologic Medications,N/A,N/A,410,Percentage of psoriasis patients receiving oral systemic or biologic therapy who meet minimal physician- or patient-reported disease activity levels. It is implied that establishment and maintenance of an established minimum level of disease control as measured by physician- and/or patient-reported outcomes will increase patient satisfaction with and adherence to treatment.,Person and Caregiver-Centered Experience and Outcomes,Outcome,American Academy of Dermatology,-,-,X,-,-,-,-,X,-,-,,,,,,Measure Specification Manuals
,Depression Remission at Six Months,N/A,0711,411,Adult patients age 18 years and older with major depression or dysthymia and an initial PHQ-9 score > 9 who demonstrate remission at six months defined as a PHQ-9 score less than 5. This measure applies to both patients with newly diagnosed and existing depression whose current PHQ-9 score indicates a need for treatment.,Communication and Care Coordination,Outcome,Minnesota Community Measurement,-,-,-,-,-,-,-,X,-,-,,,,,,Measure Specification Manuals
,Documentation of Signed Opioid Treatment Agreement,N/A,N/A,412,All patients 18 and older prescribed opiates for longer than six weeks duration who signed an opioid treatment agreement at least once during Opioid Therapy documented in the medical record.,Effective Clinical Care,Process,American Academy of Neurology,-,-,-,-,-,-,-,X,-,-,,,,,,Measure Specification Manuals
,Door to Puncture Time for Endovascular Stroke Treatment,N/A,N/A,413,Percentage of patients undergoing endovascular stroke treatment who have a door to puncture time of less than two hours.,Effective Clinical Care,Intermediate Outcome,Society of Interventional Radiology ,-,-,-,-,-,-,-,X,-,-,,,,,,Measure Specification Manuals
,Evaluation or Interview for Risk of Opioid Misuse,N/A,N/A,414,"All patients 18 and older prescribed opiates for longer than six weeks duration evaluated for risk of opioid misuse using a brief validated instrument (e.g. Opioid Risk Tool, SOAAP-R) or patient interview documented at least once during Opioid Therapy in the medical record.",Effective Clinical Care,Process,American Academy of Neurology,-,-,-,-,-,-,-,X,-,-,,,,,,Measure Specification Manuals
,Emergency Medicine: Emergency Department Utilization of CT for Minor Blunt Head Trauma for Patients Aged 18 Years and Older,N/A,N/A,415,Percentage of emergency department visits for patients aged 18 years and older who presented within 24 hours of a minor blunt head trauma with a Glasgow Coma Scale (GCS) score of 15 and who had a head CT for trauma ordered by an emergency care provider who have an indication for a head CT.,Efficiency and Cost Reduction,Efficiency,American College of Emergency Physicians,-,-,X,-,-,-,-,X,-,-,,,,,,Measure Specification Manuals
,Emergency Medicine: Emergency Department Utilization of CT for Minor Blunt Head Trauma for Patients Aged 2 through 17 Years,N/A,N/A,416,Percentage of emergency department visits for patients aged 2 through 17 years who presented within 24 hours of a minor blunt head trauma with a Glasgow Coma Scale (GCS) score of 15 and who had a head CT for trauma ordered by an emergency care provider who are classified as low risk according to the Pediatric Emergency Care Applied Research Network  prediction rules for traumatic brain injury. ,Efficiency and Cost Reduction,Efficiency,American College of Emergency Physicians,-,-,X,-,-,-,-,X,-,-,,,,,,Measure Specification Manuals
,Rate of  Open Repair of Ascending Abdominal  Aortic Aneurysms (AAA) Where Patients Are Discharged Alive  ,N/A,1523,417,Percentage of patients undergoing open repair of abdominal aortic aneurysms (AAA) who are discharged alive.,Patient Safety,Outcome,Society for Vascular Surgeons,-,-,-,-,-,-,-,X,-,-,,,,,,Measure Specification Manuals
,"Osteoporosis Management in Women Who Had a Fracture 
",N/A,0053,418,The percentage of women age 50-85 who suffered a fracture and who either had a bone mineral density test or received a prescription for a drug to treat osteoporosis.,Effective Clinical Care,Process,National Committee for Quality Assurance,American Medical Association-Physician Consortium for Performance Improvement,-,X,-,-,-,-,X,-,-,-,-,-,-,-,Measure Specification Manuals
,Overuse Of Neuroimaging For Patients With Primary Headache And A Normal Neurological Examination,N/A,N/A,419,Percentage of patients with a diagnosis of primary headache disorder for whom advanced brain imaging was not ordered.,Efficiency and Cost Reduction,Efficiency,American Academy of Neurology,,,X,-,-,-,-,X,-,-,,,,,,Measure Specification Manuals
,Varicose Vein Treatment with Saphenous Ablation: Outcome Survey ,N/A,N/A,420,Percentage of patients treated for varicose veins (CEAP C2-S) who are treated with saphenous ablation (with or without adjunctive tributary treatment) that report an improvement on a disease specific patient reported outcome survey instrument after treatment.,Effective Clinical Care,Process,Society of Interventional Radiology ,-,-,-,-,-,-,-,X,-,-,,,,,,Measure Specification Manuals
,Appropriate Assessment of Retrievable Inferior Vena Cava Filters for Removal,N/A,N/A,421,"Percentage of patients in whom a retrievable IVC filter is placed who, within 3 months post-placement, have a documented assessment for the appropriateness of continued filtration, device removal or the inability to contact the patient with at least two attempts",Effective Clinical Care,Outcome,Society of Interventional Radiology ,-,-,-,-,-,-,-,X,-,-,,,,,,Measure Specification Manuals
,Performing Cystoscopy at the Time of Hysterectomy for Pelvic Organ Prolapse to Detect Lower Urinary Tract Injury,N/A,2063,422,Percentage of patients who undergo cystoscopy to evaluate for lower urinary tract injury at the time of hysterectomy for pelvic organ prolapse.,Patient Safety,Process,American Urogynecologic Society,-,-,X,-,-,-,-,X,-,-,,,,,,Measure Specification Manuals
,Perioperative Anti-platelet Therapy for Patients Undergoing Carotid Endarterectomy,N/A,0465,423,"Percentage of patients undergoing carotid endarterectomy (CEA) who are taking an anti-platelet agent (aspirin or clopidogrel or equivalent such as aggrenox/tiglacor, etc.) within 48 hours prior to surgery and are prescribed this medication at hospital discharge following surgery.",Effective Clinical Care,Process,Society for Vascular Surgeons,-,-,X,-,-,-,-,X,-,-,,,,,,Measure Specification Manuals
,Perioperative Temperature Management,N/A,2681,424,"Percentage of patients, regardless of age, who undergo surgical or therapeutic procedures under general or neuraxial anesthesia of 60 minutes duration or longer for whom at least one body temperature greater than or equal to 35.5 degrees Celsius (or 95.9 degrees Fahrenheit) was recorded within the 30 minutes immediately before or the 15 minutes immediately after anesthesia end time",Patient Safety,Process,American Society of Anesthesiologists,-,-,-,-,-,-,-,X,-,-,,,,,,Measure Specification Manuals
,Photodocumentation of Cecal Intubation,N/A,N/A,425,The rate of screening and surveillance colonoscopies for which photodocumentation of landmarks of cecal intubation is performed to establish a complete examination,Effective Clinical Care,Process,American College of Gastroenterology,American Gastroenterological Association,American Society for Gastrointestinal Endoscopy,X,-,-,-,-,X,-,-,,,,,,Measure Specification Manuals
,Post-Anesthetic Transfer of Care Measure: Procedure Room to a Post Anesthesia Care Unit (PACU):  ,N/A,N/A,426,"Percentage of patients, regardless of age, who are under the care of an anesthesia practitioner and are admitted to a PACU in which a post-anesthetic formal transfer of care protocol or checklist which includes the key transfer of care elements is utilized",Communication and Care Coordination,Process,American Society of Anesthesiologists,-,-,-,-,-,-,-,X,-,-,,,,,,Measure Specification Manuals
,Post-Anesthetic Transfer of Care: Use of Checklist or Protocol for Direct Transfer of Care from Procedure Room to Intensive Care Unit (ICU),N/A,N/A,427,"Percentage of patients, regardless of age, who undergo a procedure under anesthesia and are admitted to an Intensive Care Unit (ICU) directly from the anesthetizing location, who have a documented use of a checklist or protocol for the transfer of care from the responsible anesthesia practitioner to the responsible ICU team or team member",Communication and Care Coordination,Process,American Society of Anesthesiologists,-,-,-,-,-,-,-,X,-,-,,,,,,Measure Specification Manuals
,Pelvic Organ Prolapse: Preoperative Assessment of Occult Stress Urinary Incontinence ,N/A,N/A,428,Percentage of patients undergoing appropriate preoperative evaluation for the indication of stress urinary incontinence per ACOG/AUGS/AUA guidelines,Effective Clinical Care,Process,American Urogynecologic Society,-,-,-,-,-,-,-,X,-,-,,,,,,Measure Specification Manuals
,Pelvic Organ Prolapse: Preoperative Screening for Uterine Malignancy ,N/A,N/A,429,Percentage of patients who are screened for uterine malignancy prior to surgery for pelvic organ prolapse.,Patient Safety,Process,American Urogynecologic Society,-,-,X,-,-,-,-,X,-,-,,,,,,Measure Specification Manuals
,Prevention of Post-Operative Nausea and Vomiting (PONV) – Combination Therapy,N/A,N/A,430,"Percentage of patients, aged 18 years and older, who undergo a procedure under an inhalational general anesthetic, AND who have three or more risk factors for post-operative nausea and vomiting (PONV), who receive combination therapy consisting of at least two prophylactic pharmacologic antiemetic agents of different classes preoperatively or intraoperatively",Patient Safety,Process,American Society of Anesthesiologists,-,-,-,-,-,-,-,X,-,-,,,,,,Measure Specification Manuals
,Preventive Care and Screening: Unhealthy Alcohol Use: Screening & Brief Counseling,N/A,2152,431,Percentage of patients aged 18 years and older who were screened at least once within the last 24 months for unhealthy alcohol use using a systematic screening method AND who received brief counseling if identified as an unhealthy alcohol user,Community/Population Health,Process,American Medical Association-Physician Consortium for Performance Improvement,-,-,-,-,-,-,X,X,Preventive Care,X,,,,,,Measure Specification Manuals
,Proportion of Patients Sustaining a Bladder Injury at the Time of any Pelvic Organ Prolapse Repair,N/A,N/A,432,Percentage of patients undergoing any surgery to repair pelvic organ prolapse who sustains an injury to the bladder recognized either during or within 1 month after surgery ,Patient Safety,Outcome,American Urogynecologic Society,-,-,-,-,-,-,-,X,-,-,,,,,,Measure Specification Manuals
,Proportion of Patients Sustaining a Major Viscus Injury at the Time of Any Pelvic Organ Prolapse Repair,N/A,N/A,433,Percentage of patients undergoing surgical repair of pelvic organ prolapse that is complicated by perforation of a major viscus at the time of index surgery that is recognized intraoperative or within 1 month after surgery,Patient Safety,Outcome,American Urogynecologic Society,-,-,-,-,-,-,-,X,-,-,,,,,,Measure Specification Manuals
,Proportion of Patients Sustaining A Ureter Injury at the Time of any Pelvic Organ Prolapse Repair,N/A,N/A,434,Percentage of patients undergoing a pelvic organ prolapse repair who sustain an injury to the ureter recognized either during or within 1 month after surgery,Patient Safety,Outcome,American Urogynecologic Society,-,-,-,-,-,-,-,X,-,-,,,,,,Measure Specification Manuals
,Quality Of Life Assessment For Patients With Primary Headache Disorders,N/A,N/A,435,Percentage of patients with a diagnosis of primary headache disorder whose health related quality of life (HRQoL) was assessed with a tool(s)* during at least two visits* during the 12 month measurement period AND whose health related quality of life score stayed the same or improved. ,Effective Clinical Care,Outcome,American Academy of Neurology,-,-,X,-,-,-,-,X,-,-,,,,,,Measure Specification Manuals
,Radiation Consideration for Adult CT: Utilization of Dose Lowering Techniques,N/A,N/A,436,"Percentage of final reports for patients aged 18 years and older undergoing CT with documentation that one or more of the following dose reduction techniques were used:
• Automated exposure control
• Adjustment of the mA and/or kV according to patient size
• Use of iterative reconstruction technique
",Effective Clinical Care,Process,American College of Radiology,American Medical Association-Physician Consortium for Performance Improvement,National Committee for Quality Assurance,X,-,-,-,-,X,-,-,,,,,,Measure Specification Manuals
,Rate of Surgical Conversion from Lower Extremity Endovascular Revasculatization Procedure ,N/A,N/A,437,"Inpatients assigned to endovascular treatment for obstructive arterial disease, the percent of patients who undergo unplanned major amputation or surgical bypass within 48 hours of the index procedure.",Patient Safety,Outcome,Society of Interventional Radiology ,-,-,X,-,-,-,-,X,-,-,,,,,,Measure Specification Manuals
,Statin Therapy for the Prevention and Treatment of Cardiovascular Disease,N/A,N/A,438,"Percentage of the following patients—all considered at high risk of cardiovascular events—who were prescribed or were on statin therapy during the measurement period: 
• Adults aged ≥ 21 years who were previously diagnosed with or currently have an active diagnosis of clinical atherosclerotic cardiovascular disease (ASCVD); OR 
• Adults aged ≥21 years with a fasting or direct low-density lipoprotein cholesterol (LDL-C) level ≥ 190 mg/dL; OR 
• Adults aged 40-75 years with a diagnosis of diabetes with a fasting or direct LDL-C level of 70-189 mg/dL
",Effective Clinical Care,Process,Centers for Medicare & Medicaid Services,Mathematica,Quality Insights of Pennsylvania,-,-,-,X,X,X,Cardiovascular Prevention,-,,,,,,Measure Specification Manuals
,Age Appropriate Screening Colonoscopy,N/A,N/A,439,The percentage of patients greater than 85 years of age who received a screening colonoscopy from January 1 to December 31.,Efficiency and Cost Reduction,Efficiency,American Gastroenterological Association,American Society for Gastrointestinal Endoscopy,American College of Gastroenterology,-,-,-,-,-,X,-,-,,,,,,Measure Specification Manuals